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ABSTRACT: 
BACKGROUND: 
 Shivering is a most commonly encountered problem during  both  
intraoperative and post operative period. It increases the oxygen consumption 
significantly  so it  can be detrimental to patients with poor cardiac reserve and also 
increases intracranial pressure and intraocular pressure.  The present study 
evaluated the efficacies of dexmedetomidine and meperidine in the prevention of 
intraoperative shivering in patients undergoing lower abdominal surgeries under 
spinal anaesthesia 
METHODS: 
 A total of 80 adult patients aged 18 to 60 years with American society of 
Anaesthesiologist physical status I and II of both the gender were randomized to 
two groups. In that group D will receive  Inj.Dexmedetomidine 0.5  mics/kg  in 
100 ml normal saline over a period of 10 minutes  and  group M will receive 
Inj.Meperidine 0.5 mg/kg in 100 ml normal saline  just after giving subarachnoid 
block with 3.5 cc of 0.5 % hyperbaric bupivacaine . Heart rate, mean arterial 
pressure, SpO2, temperature, shivering grade will be monitored for every 5 
minutes till the end of surgery. Sedation score and respiratory rate will be 
monitored every 10 minutes till the end of  surgery. 
RESULTS: 
 Both  dexmedetomidine  and pethidine  were effective in preventing the 
intraoperative  shivering. Out of 80 patients 4 patients in mepridine group and 3 
patients in dexmedetomidine group had shivering in almost similar grade. The 
sedation score was more with dexmedetomidine group with less incidence of 
nausea and vomiting when compared to the pethidne group. There was no 
statistically significant variation in haemodynamics in both the groups. 
CONCLUSION: 
 Intravenous administration of dexmedetomidine and meperidine was 
effective in prevention of shivering  in patients undergoing lower abdominal 
surgeries under spinal anaesthesia.  Dexmedetomidine  produces  lesser side effects 
like nausea and vomiting  with more sedation without causing respiratory 
depression when compared with pethidine.  So dexmedetomidine can be used as an 
effective drug in prevention of intraoperative shivering 
KEYWORDS:  
 Subarachnoid block, shivering, sedation, meperidine and Dexmedetomidine. 
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INTRODUCTION 
 Spinal anaesthesia is one of the most popular and commonly used 
anaesthetic  procedures for both elective and emergency surgeries. It is a 
simple, cost effective and efficient technique that provides complete 
sensory and motor blockade as well as postoperative analgesia with a 
high success rate. Like general anaesthesia and peripheral  nerve 
blockade, spinal anaesthesia has its own complications like hypotension, 
bradycardia, urinary retention, meningitis, shivering etc.  Among those 
complications, shivering is the most commonly encountered problem 
during both central neuraxial blockade and general anaesthesia. Though 
shivering is found commonly after general anaesthesia  about 19-33% of 
the patients undergoing surgical procedures under regional anaesthesia 
develop shivering1.  
 The mechanism of shivering in patients undergoing surgery under 
spinal anaeshesia  is not clearly explained but the  probable  mechanism  
is the inhibition of thermoregulation which causes vasodilation and  
redistribution  of  blood flow  from trunk to the peripheral tissues distal  
to the blockade and  thereby reducing the  shivering  threshold2.  
 Shivering is a very unpleasant and physiologically stressful 
symptom for the patients undergoing surgery and it occurs in various 
frequencies as a thermoregulatory response to hypothermia or muscle 
activity with tonic or clonic patterns. Shivering obscures intraoperative 
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monitoring like ECG, SPO2, blood pressure monitoring and also 
increases the intraocular and intracranial pressure3,4,5. It can be 
detrimental to patients with low cardio-respiratory reserve since it 
increases oxygen demand and consumption, produce arterial hypoxemia, 
lactic acidosis. Some patients find the accompanying cold sensation to be 
worse than the surgical pain.  
 Various   methods are available for the control   of   shivering 
during anaesthesia. Non-pharmacological methods like electrical heaters, 
radiant warmers are being used to maintain normothermia.  But the 
equipments used to maintain normothermia may not be practical in all the 
settings6. Drugs like pethidine[meperidine], tramadol, clonidine, 
nefopam, ketamine have been tried to prevent/treat shivering during 
spinal anesthesia. Many drugs have been found effective in controlling 
shivering but  most of them produced significant adverse effects like 
nausea, vomiting and respiratory depression.  
 This resulted in finding an alternate drug for control of shivering. 
Dexmedetomidine (highly selective 2 agonist) is a new drug approved 
for sedation of critically ill or injured patients in intensive care unit. It 
produces sedation, anxiolysis, hypnosis, analgesia, sympatholysis and has 
anti shivering properties. Since it has got lesser side effects than other 
antishivering agents, this study is conducted to find the effectiveness of 
dexmedetomidine in the prevention of shivering. 
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AIMS & OBJECTIVES 
 
1. To study and compare the effectiveness of dexmedetomidine and 
meperidine in the prevention of intraoperative shivering in patients 
undergoing lower abdominal surgeries under spinal anesthesia. 
 
2. To study the side effects of the drugs.  
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REVIEW OF LITERATURE 
Thermoregulation  
The central regulation of body temperature is by feedback 
mechanisms that operate predominantly through the preoptic nucleus of 
anterior   hypothalamus. This area integrates afferent inputs from thermo 
receptors in skin, deep tissues and spinal cord. However, now it is known 
that considerable modulation of afferent thermoregulatory input occurs in 
the brain stem and spinal cord before arrival in hypothalamus.   
 
There are three components involved in the processing of 
thermoregulatory response (Figure 1) which includes:  
1. Afferent thermal sensing,  
2. Central regulation (Figure 2) and  
3. Efferent responses.  
 
These three components work together to maintain normal core 
body temperature7,8,9. General anaesthesia affect all the three components 
and regional anaesthesia affect the afferent and efferent components 
which is responsible for the occurrence of perioperative hypothermia.    
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Figure 1: Physiology of thermoregulation 
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Figure 2: Neural pathway for shivering 
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Afferent thermal sensing  
Information on temperature is obtained from thermally sensitive 
cells throughout the body. Thermoreceptors  are  of two types  namely 
warm  sensory receptors and cold sensory receptors. These receptors are 
responsible for sensing cold and warm temperatures and are located both 
centrally as well as peripherally. Cold signals are carried by the A delta 
fibres and warm signals by unmyelinated C fibres10. These thermal signal 
reaches hypothalamus (the central thermoregulatory centre) via the lateral 
spinothalamic tract. Before reaching the hypothalamus,  these signal  gets 
integrated and modulated  at the level of the spinal cord. Signal from cold 
receptors which  travel via the delta fibres  have a peak discharge of 
impulses at temperature between  25°C to 30°C,  whereas  signal  from  
warm  receptors  which travel  via  unmyelinated  C fibres  have a 
maximal discharge at 45°C to 50°C. In addition, there are also central 
cold receptors whose anatomical location is uncertain.  
Peripheral cold sensory receptors are more effective when 
compared to central cold thermoreceptors. Studies conducted in spinal 
cord transection patients have showed that thermoregulatory central 
process is less sensitive when compared to peripheral thermoreceptor.  
These central thermo receptors become active when the temperature set 
point falls below its level.  
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Anterior spinothalamic tracts in the spinal cord transmit most of the 
thermal sensation to the brain. No single tract is responsible for 
transmitting whole of thermal sensation. Hence to completely abolish 
thermal sensation we need to destroy the whole of anterior spinal cord. 
Spinal cord acts as a gateway at multiple levels for sensing and modifying 
the thermal signals before reaching the hypothalamus which is the 
primary thermoregulatory control in mammals. 
   Before reaching the hypothalamus few areas in brain stem such as 
sub coeruleus  and  the raphe  magnus nucleus acts as a relay station for 
transmitting thermal information from skin. Roughly about 20% of the 
total thermal input comes from various  structures like hypothalamus, 
spinal cord, skin surface, deep abdominal and thoracic tissues to the 
central regulatory system12.  
 
The Subcoeruleus area and Nucleus Raphe Magnus  
The locus subcoeruleus contains numerous noradrenergic neurons 
and it is located ventromedial  to the locus coeruleus in pons. The raphe 
magnus nucleus situated in the medulla contains large amount of 
thermoresponsive (predominantly warm responsive) serotonergic 
neurons14.  
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Central regulation  
The dominant autonomic thermoregulatory controller in mammals 
is the preoptic  region of the hypothalamus. The anterior hypothalamus is 
responsible for integration of afferent thermal information, whereas the 
posterior hypothalamus mainly controls the descending pathways to the 
effectors.  The temperature sensitive and insensitive neurons are situated 
in the pre-optic area of hypothalamus. The temperature insensitive 
neurons respond to non thermal information such as plasma osmolality, 
reproductive hormones, glucose concentration, BP (Blood Pressure), 
noxious stimuli, CO2 and emotional stimuli. The temperature sensitive 
neurons are divided into heat and cold responsive neurons. The heat 
responsive neurons in the preoptic area are about four times higher than 
the cold sensitive neurons. The heat responsive neurons increase their 
discharge rate and activate heat loss mechanism in response to increased 
local heat. Cold responsive neurons get triggered when cold sensation 
from skin reaches the hypothalamic preoptic area. 
The hippocampus connects the limbic system (emotion, memory, 
and behaviour) to thermoregulatory responses by delivering much of 
excitatory inputs to the warm responsive neurons. Warm responsive 
neurons compare all the non thermal and thermal inputs from spinal cord 
with the local information and it also senses the core temperature. Though 
the thermal informations are integrated by hypothalamus, most of them 
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are pre processed in spinal cord and other parts of central nervous system 
before reaching the hypothalamus.  
         The body temperature varies during sleep and circadian rhythm 
mainly due to the changes in the activity of neurons in the ascending 
reticular activating system and suprachiasmatic nucleus which modulates 
the thermoregulatory centre in the hypothalamus13,14 . 
   The gain of thermoregulatory response was defined as the slope of 
response between intensity and core temperature. The response intensity 
which is no longer increasing with further deviation in core temperature 
identifies the maximum intensity. This system of gains and thresholds is a 
model for a thermoregulatory system which is complicated by 
interactions between other thermoregulatory responses such as vascular 
volume control and time dependent effects.    
         The four neural mechanisms responsible for autonomic 
thermoregulation are:  
1. Peripheral detection of cold  
2. Central detection of warmth 
3. Inhibition of thermoregulatory sweating by cooling of skin  
4. Central warm inhibition of metabolic response to cold 
The mechanism for the absolute threshold temperature determined 
by the body is largely not known, though the  mechanism appears to be 
mediated by the chemical mediators like norepinephrine, acetylcholine, 5-
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HT, dopamine, neuropeptides and prostaglandin E1. Thresholds vary 
daily in both sexes (circadian rhythm) and monthly in women during 
menstruation by approximately 0.5°C. Exercise, food intake, infection, 
hyperthyroidism, hypothyroidism,  anaesthetic and other drugs, cold and 
warm adaptation etc alter threshold temperatures.  
  Approximately 80% of control of autonomic response is 
determined by thermal input from core structures15. But in contrast, a 
large fraction of behavioral response is derived from skin surface. The 
inter threshold  range (core temperature not triggering autonomic 
thermoregulatory responses) is only 0.4°C (36.7°C to 37.1°C).This 
threshold has vasoconstriction at its lower end and sweating  at its  upper 
end . During general anaesthesia in volunteers this inter-threshold may be 
increased up to 4.0°C.  
The vasoconstriction  and  sweating  thresholds ( Figure 3) are 
0.3°C-0.5°C higher in women than men. In women, it is even higher in 
the follicular phase of menstrual cycle16 and also shows greater 
differences in luteal phase 17. In premature neonates, central 
thermoregulatory control is somewhat intact when compared to elderly18.  
Efferent responses  
Multiple inputs received in the effector system are integrated into a 
common efferent signal. Effector mechanisms are in an orderly fashion, 
ensuring  optimal  regulation in both animals and humans. The body 
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responds to thermal perturbations  by activating effector mechanisms that 
acts by altering the environmental heat loss or increasing the metabolic 
heat production. Each thermoregulatory effector has its own threshold 
and gain and so there is an orderly progression of responses and response 
intensities in proportion to the need7.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Relationship between core temperature and mean skin 
temperature triggering shivering and vasoconstriction 
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The thermoregulatory responses (Figure 4) are characterized by:-  
 
1. Altered behaviour, quantitatively the most effective mechanism.  
2. Vasomotor response, consisting of vasodilatation, sweating in 
response to heat and vasoconstriction and piloerection in response 
to cold.  
3. Shivering and increase in metabolic rate7.  
 
For a given individual, at specific temperature the activation of 
thermoregulatory effector response is triggered. Behaviour modification 
plays a powerful role in regulating body temperature in conscious 
individuals when compared to the autonomic regulatory mechanisms.  
 
When an excessively cool body temperature is sensed by the 
hypothalamus and from there the impulses reaches the cerebral cortex 
giving cold sensation to the individual. It results in behavior 
modifications like increased motor activity, adding clothing or moving to 
warmer surroundings7. 
The  autonomic effector responses are activated when the set point 
temperature range of 36.7°C to 37.1°C is  breached . Each of the specific 
responses  has a characteristic threshold, gain and maximum response 
intensity. 
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Figure 4: Thermoregulatory effector responses at specific 
temperatures in Normal  and  anaesthetised individuals 
 
Cutaneous vasoconstriction is the most consistently used 
autonomic effector mechanism. Heat loss is normally regulated by 
vasomotor changes like cutaneous vasoconstriction and vasodilation 
without the major responses like sweating or shivering. 
Thermoregulatory cutaneous vasoconstriction preserves metabolic 
heat and thereby preventing the decrease in body temperature. Shivering 
is the last defence  that is activated only when behavioural compensation 
and maximum A-V shunt vasoconstriction are insufficient to maintain 
core temperature.  Metabolic heat is lost primarily through convection 
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and radiation from the skin surface, vasoconstriction reduces this loss. 
The digital blood flow in total is divided into thermoregulatory (mostly 
A-V shunt) vasoconstriction and  nutritional (mostly capillary)7.  
The central temperature system has biologic rhythms. Fluctuations in core 
temperature occur daily with the lowest temperatures occurring in the 
early hours of morning in relation to melatonin secretion. These circadian 
rhythms can produce variation of up to 1.5°C.  
Shivering  
 Shivering is an involuntary, oscillatory muscular activity which 
augments metabolic heat production up to 600% above baseline. 
However, a doubling of metabolic heat production is all that can be 
sustained over long periods.  The electromyographic study in humans 
showed that the fundamental tremor frequency to be around 200 Hz. 
Further, it also indicated that the tremor had a 4–8 cycles/ min, waxing-
and-waning pattern (Figure 5)14.  
When the cold stimulus reaches preoptic region, the efferent 
signals passed along the medial forebrain bundle which resulted in 
shivering.  The posterior hypothalamus is inhibited by the preoptic-
anterior hypothalamus in order to suppress shivering. The central 
descending pathway of shivering was thought to arise from the posterior 
hypothalamus. It is yet to be determined whether the synaptic inputs for 
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the reticulospinal neurons are from the posterior hypothalamus or from 
the preoptic-anterior hypothalamus14. 
The final common pathway for both the shivering and coordinated 
movement is through the spinal motor neurons and their axons. The 
electromyography showed a specific rhythm for cold tremors in the form 
of grouped discharges. The excitability of motor neurons is inversely 
proportional to cell size. The motor neurons are recruited in the sequence 
of increasing size when there was a continuous cold stimulus to the skin 
or spinal cord.  
During shivering, the larger motor neurons show synchronized 
discharges than the smaller ones which is due to the recurrent inhibition 
of  Renshaw cells(a group of inhibitory interneuron)14. 
 
 
 
 
 
 
 
 
 
Figure 5: Patterns of shivering (waxing and waning). 
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Thermoregulation during general anaesthesia 
Major disturbances in thermoregulation are observed during and 
after general anaesthesia. The inductions of general anaesthesia impair 
the function of neurons in the preoptic nuclei and hypothalamus, thereby 
reducing the temperature at which activation of responses to hypothermia 
usually occurs.  Behavioural adaptations are not relevant in a patient 
under general anaesthesia who is unconscious and frequently paralysed. 
All general anaesthetics tested markedly inhibit autonomic 
thermoregulatory control. Anesthetic induced thermoregulation slightly 
elevates the warm response and markedly reduces cold response 
threshold. The inter-threshold range is increased from its normal value of 
near 0.2°C to approximately 2°C-4°C. The gain and maximum intensity 
of some responses remain normal, whereas others are reduced by general 
anesthesia7.  
Thermoregulation during regional anaesthesia  
Epidural and spinal anaesthesia alter the thermoregulatory response 
by decreasing the vasoconstriction and shivering threshold to a 
comparable degree (by 0.6°C) to general anaesthesia, but to a lesser 
amount than when measured at the level above the upper level of the 
block.  
In regional anaesthesia, the gain and maximum intensity of 
shivering response is reduced by 63% and 33% respectively. But in case 
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of general anaesthesia the gain of thermoregulatory responses is 
unchanged.  This occurs because shivering above block compensates for 
the inability of muscle group below the level of blockade to engage in 
shivering. As with general anaesthesia, during first hour of epidural 
anaesthesia core temperature decreases by 0.6-1.5°C due to core-to-
peripheral distribution of heat due to epidural induced vasodilatation. 
However, with prolonged epidural anaesthesia, it was observed that the 
degree of core hypothermia is less than that of general anaesthesia. This 
is explained by the fact that vasoconstriction above the block 
compensates for heat losses in regional anaesthesia7. 
Shivering during regional anaesthesia is similar to that occurring 
after general anaesthesia and is preceded by core hypothermia and 
vasoconstriction above the blockade level. It has the same 
electromyography characteristics as that of shivering which occurs after 
general anaesthesia. With reduced gain and maximum intensity, the 
shivering which is induced by core hypothermia following regional 
anaesthesia is usually ineffective in preventing core hypothermia.  
Whether shivering observed following regional anaesthesia during labour 
is due to the temperature of the injectate is unclear. Incidence of shivering 
was significantly lower in parturients who received pre warmed local 
anesthetic when compared to cold local anesthetic. These results could 
not be demonstrated in non pregnant individuals.  
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Interestingly, core hypothermia during regional anaesthesia (Figure 6) 
may not trigger a sensation of cold. This may reflect the fact that 
subjective cold perception depends on skin temperature afferent input, 
and that cutaneous vasodilatation resulting from regional anaesthesia 
increases skin temperature, leading to sensation of warmth although 
accompanied by thermoregulatory shivering. Awareness of core 
hypothermia is also impaired by epidural anaesthesia. During induction of 
general and regional anaesthesia the body heat is redistributed from the 
core to periphery and subsequent development of hypothermia depends 
on balance of cutaneous heat loss and rate of metabolic heat production7. 
Patterns of intraoperative hypothermia 
Hypothermia during general anaesthesia has a characteristic pattern 
which include 3 phases namely, 
1. Initial rapid decrease.  
2. Slow linear reduction.  
3. Stabilization of core temperature. 
The final plateau phase may be a passive thermal steady state and 
triggers thermoregulatory vasoconstriction when sufficient hypothermia 
develops. 
Temperature monitoring should be accurate in determining 
temperature. Mercury-in-glass thermometers which were used earlier 
were slow and cumbersome and so, now they are replaced by electronic 
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thermometers. The most commonly used systems are thermistors and 
thermocouples. Both these devices are accurate and are inexpensive. 
Infrared monitors used for tympanic membrane temperature monitoring 
from outer ear are also available. Due to variation in the core body 
temperature during the perioperative period there will be variation in the 
temperatures measured at various body site. Core temperature can be 
monitored at nasopharynx, tympanic membrane, distal part of the 
oesophagus, and pulmonary artery. The core thermal compartment 
contains highly perfused tissues whose temperature is high when 
compared to rest of the body. Core temperature can be measured with 
reasonable accuracy using oral, rectal, axillary and bladder temperatures 
also. 
 
 
 
 
 
 
             
 
Figure 6 : Core temperature after administration of anaesthesia. 
Temperature monitoring 
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Complications of hypothermia and shivering 
Complications of hypothermia  and shivering include increased 
blood loss & reversible coagulopathy, increased blood transfusion, 
impaired wound healing, increased risk of infection, delayed drug 
metabolism, left shift of haemoglobin – oxygen dissociation curve, 
altered mental status, cardiac arrhythmias and Ischemia, increased 
peripheral vascular resistance, increased myocardial oxygen 
consumption, increased basal metabolic rate and monitoring artifacts 
showing aberrant values20,21,22. 
 
Measures to combat shivering  
Measures which reduce core hypothermia in turn reduce 
anaesthesia induced shivering. They include:  
 
1. Passive insulators   
Passive insulators include cotton blankets, cloth or paper surgical 
drapes, disposable plastic drapes and plastic bags. Passive insulators 
reduce heat loss to environment. Heat conservation is proportional to the 
area of body covered. A single layer of each type of covering material 
decreases heat loss by approximately 30%. Unfortunately adding 
additional layers does not proportionately increase the benefit. However, 
this is not beneficial in long and extensive surgeries7.  
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2. Active warming  
Convection warming system use warmed air that is forced through 
a quilt like porous blanket over the skin, warming it directly and also 
replacing the normal body “air envelope”  with a warm air envelop (Bair 
Hugger Unit).This is the most effective system for conservation of body 
heat.  Radiant heat system like infra red light, thermal ceiling lights can 
be used for warming the body.  Other measures like warming inspired air, 
warming intravenous fluids, blood and blood components before infusion, 
maintaining warm post-operative environment are useful in preserving 
body temperature and reducing shivering7.  
3. Pharmacotherapy  
Many drugs like tramadol, pethidine, nefopam, ketanserine, 
ketamine, fentanyl, clonidine and dexmedetomidine have potent anti-
shivering properties. These drugs belongs to several classes like biogenic 
monoamines, endogenous peptides, cholinomimetics, endogenous 
peptides and possibly N-Methyl-D- Aspartate (NMDA) antagonist, 5HT, 
noradrenaline receptor antagonists. All these drugs exert their action by 
modulating the central thermoregulatory control mechanisms. The normal 
functions of these drugs are diverse and the predominant site of action of 
most of these drugs  are yet to be identified7. 
Meperidine decreases the shivering threshold almost twice as much 
as the vasoconstriction threshold and is more effective than that of pure µ 
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receptor agonists in the treatment of shivering. The antishivering activity 
of meperidine is also partially mediated by κ opioid receptors. 
Magnesium sulphate is a physiologically occurring NMDA receptor 
antagonist and has anti shivering properties. Ketamine  is  another 
competitive NMDA receptor antagonist, shown to be effective against 
shivering.  Clonidine and Dexmedetomidine are α2 receptor agonists, 
used for the prevention of shivering. Recently, granisetron an anti emetic 
drug whose role in prevention of shivering is under study. 
 
DEXMEDETOMIDINE 
It is a selective α2 agonist which produces sedation, anxiolysis, 
analgesia and also possess sympatholytic property.  Because of these 
properties, dexmedetomidine has made its use in perioperative period and 
for sedation of patients admitted in intensive care unit. It also has got anti 
shivering property. Various studies are being conducted to find out the 
effectiveness of dexmedetomidine in control of shivering. 
 
Physical and chemical properties: 
Dexmedetomidine (Figure 7) is a d-enantiomer of medetomidine, 
belonging to the imidazole subclass of α2 receptor agonists. It is highly 
water soluble. It has a high specificity for α2 receptor (α2:α1 1600:1), 
when compared to clonidine  [α 2:α 1 200:1]. Its  pka is about 7.1.  
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Figure 7: Dexmedetomidine chemical formula and vial 
 Pharmacokinetics: 
Dexmedetomidine is administered intravenously as infusion. It is a 
dextroisomer of medetomidine and is short acting with linear 
concentration dependent  kinetics. 
Dosing and Administration: 
Desirable pharmacodynamic effects are observed at a plasma 
concentration of 0.5-1.2 ng/ml. The dosing regimen approved by FDA in 
1999 is a loading dose of 1 µg/kg administered over a period of 10 
minutes followed by continuous intravenous infusion at a rate of 0.2 to 
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0.7µg/kg/hr. The rate of intravenous infusion should be titrated according 
to the desired level of sedation. The FDA approved duration of infusion is 
24 hours for ICU sedation. Dexmedetomidine when administered for less 
invasive procedure like ophthalmic surgeries is given at a loading dose of 
0.5 µg/kg over 10 minutes followed by a maintenance  infusion  which is 
started at 0.6 µg/kg/hr and titrated to achieve desired clinical effects. 
Distribution: 
The pharmacokinetics of Dexmedetomidine is commonly 
described using a two-compartment model. It is rapidly distributed after 
administration with a distribution half life of 6 minutes. The terminal 
elimination half life is approximately 2 – 2.5 hours. The steady state 
volume of distribution is approximately 68 L to 72 L. Dexmedetomidine 
is highly bound to plasma proteins (94%) without significant variations in 
pharmacokinetic parameter.    
Metabolism and Elimination: 
Dexmedetomidine undergoes almost complete biotransformation 
which results in very   little amount of drug being excreted in urine and 
faeces as unchanged form.  It is extensively metabolized in the liver 
through glucuronide conjugation and biotransformation by the 
cytochrome P450 system without formation of toxic metabolites. The 
resulting methyl and glucuronide conjugates are excreted by the kidneys. 
Dexmedetomidine is metabolised by various metabolic pathways. Direct 
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N-glucuronidation to inactive metabolites accounts for 41% of 
metabolism of dexmedetomidine. N-methylation to produce 3-hydroxy 
N-methyl-dexmedetomidine, is the next major pathway accounting for 
21% of metabolism of dexmedetomidine.  
Hydroxylation followed by conjugation is the other metabolic 
pathway of dexmedetomidine. It undergoes conjugation (41%), n-
methylation (21%), or hydroxylation followed by conjugation. The 
terminal elimination half life of dexmedetomidine is  2 hours. The 
average clearance value for dexmedetomidine is approximately 45 L/hr in 
adults. Renal and hepatic diseases greatly impair the pharmacokinetic 
properties of dexmedetomidine. Hepatic impairment results in an increase 
in the volume of distribution and half-life of dexmedetomidine as well as 
a decrease in clearance and protein binding. Renal dysfunction leads to a 
decrease in the elimination half-life, however the volume of distribution 
and clearance are not affected.  
Table 1: Pharmacokinetics of Dexmedetomidine 
Molecular Weight 236.7 Daltons 
Lipid solubility 30 
Distribution t1/2 6 min 
Protein Binding 94% 
Volume of distribution 118 L 
Elimination t1/2 120-180 min 
Context sensitive half time 4 – 250 min 
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Mechanism of action : 
α2 receptors  are found in both  central  and peripheral nervous 
system and also  in  vital organs like liver, pancreas, kidney. These 
receptors appear to possess presynaptic, postsynaptic and extrasynaptic 
sites of action.  Among those, presynaptic sites are of clinically 
significant because they play a vital role in modulating the release of 
norepinephrine and ATP. Responses to the stimulation of these receptors 
depend on its location. It is a highly selective α2 agonist mainly acts on 
the presynaptic α2 receptors and results in the suppression of  
norepinephrine  release.  Its main action  is on  the presynaptic α2 
receptors  located in the brain and spinal cord inhibiting neuronal firing 
and thereby leading to hypotension, bradycardia, sedation and analgesia. 
Pharmacodynamics: 
It exerts a brief biphasic pattern of cardiovascular response  after 
the initial administration. The bolus dose which is usually recommended  
as 1µg/kg results in initial transient rise  of blood pressure associated with 
reflex bradycardia.  This response usually lasts for 5 to 20 min and has 
been observed in many healthy young individuals. The initial rise in 
blood pressure which is mainly due to its action in α2b receptors located 
in vascular smooth muscles. The transient increase followed by slight 
decrease in blood pressure occurs mainly because of blockade of central 
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sympathetic outflow. Dexmedetomidine causes decrease in 
norepinephrine release causing further hypotension and bradycardia. The 
incidence of bradycardia in postoperative period is found to be high. So 
the careful use of the drug is recommended in patients having poor left 
ventricular function. The sedative action of dexmedetomidine is mediated 
primarily by its action on post-synaptic α2adrenoreceptors, which in turn 
exerts its action by inhibiting pertussis-toxin-sensitive G protein, thereby 
increasing conductance through potassium channels. The sedative effect 
of dexmedetomidine has been attributed to the action on locus coeruleus 
located in the brain stem. 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: Dexmedetomidine clinical effects 
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Uses: 
1. It is commonly used in ICUs for  sedation  of  intubated patients  
but should not be used more than 24 hours. Its advantage is patient 
can be easily arousable and it doesnot  produce any respiratory 
depression like other sedatives. 
2. Procedural sedation  for  surgical procedures  without  intubation. 
3. Reduces the requirement of anaesthetics and opioids during general 
anaesthesia. 
4. Used as an anxiolytic for intravenous regional anaesthesia. 
5. It is also used to attenuate the intubation response when given 
intravenously before performing laryngoscopy. 
6. It  has  got  anti shivering  property also. The anti‑shivering 
effectsof alpha adrenoceptor agonists are mediated by binding to a2 
receptors that mediate vasoconstriction and the anti‑shivering 
effect. In addition, it has hypothalamic thermoregulatory effects. 
Dexmedetomidine comparably reduces the vasoconstriction and 
shivering thresholds, thus suggesting that it acts on the central 
thermoregulatory mechanism rather than peripheral mechanism. 
Various studies are being conducted to find out the  effectiveness 
of dexmedetomidine in both prevention and treatment  of shivering 
following both general and regional anaesthesia. 
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7. It is used as an adjunct to spinal anaeshesia and peripheral nerve 
blocks. 
 
  Adverse effects: 
1. Hypotension  
2. Bradycardia, sinus arrest 
3. Transient hypertension 
4. Hypoxia 
5. Dry mouth ,nausea and vomiting 
6. Withdrawal symptoms like head ache, agitation, nervousness when           
used   for more than 24 Hours. 
7. Fever, tachycardia,  
8. Atrial fibrillation 
9. Anaemia 
 
Contraindications: 
1. Hypersensitivity to drug 
2. Severe  ventricular dysfunction 
3. Advanced heart blocks 
4. patient in shock/hypovolemia 
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MEPERIDINE [PETHIDINE] 
Pethidine is  a  synthetic opioid analgesic which was first 
synthesized by the German chemist Otto Eislib. Initially it was used for 
its potent anticholinergic property later its analgesic properties were 
recognized. Since then it was widely used for analgesic, antishivering 
property. 
 
 
 
 
 
 
Chemical name: 
Ethyl 1-methyl-4-phenylpiperidine-4-carboxylate hydrochloride 
Chemical structure: 
 
                                  
 
 
 
 
Figure 9: Chemical name and structure of  pethidine 
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Pharmacology: 
It is a synthetic opioid analgesic whose effects are similar to 
morphine. In addition to its analgesic properties its action on CNS causes 
drowsiness, sedation, euphoria, respiratory depression, dysphoria, nausea, 
vomiting and EEG changes. It can cause excitation and convulsions when 
used in large doses. It also has local anaesthetic property but it can cause 
local irritation when applied. 
Mechanism of action:  
Pharmacological actions of opioid are generally exerted by its 
interaction with stereo-specific opioid receptors located in both central 
and peripheral nervous system 
1. It acts at the µ-opioid receptor which is responsible for the 
analgesic effect. 
2. It acts at the κ-opioid receptors which is responsible for the anti 
shivering effect. 
3. It has interactions with sodium ion channel which is responsible for 
the     local anaesthetic  property. 
4. Its structure is similar to atropine and tropane alkaloids and so has      
their effects and side effects. 
5. It inhibits the dopamine transporter and  norepinephrine transporter 
by which it has stimulant effects. 
6. It has certain interactions with serotonergic neurons. 
 
 
33 
 
Onset of action is faster due to higher lipid solubility. Its clinical effect 
lasts for 120-150 minutes.  It can cause physical dependence or addiction 
like other opioids. It is associated with more euphoria, confusion, 
cognitive and impaired psychomotor performance. The side effects of 
pethidine are primarily due to action of its metabolite norpethidine. 
Pharmacokinetics 
Absorption: 
Pethidine is administered as intramuscular, intravenous or 
subcutaneous injection. When given as intramuscular injection the 
absorption is variable. Analgesia effect usually lasts for two to four hours 
following intravenous, intramuscular, and subcutaneous administration. 
Distribution: 
Pethidine is extensively distributed extravascularly mainly into 
rapidly perfused tissues. Volume of distribution is 4.17 l/kg. Plasma 
protein binding is 64.3%. 
Metabolism: 
Pethidine is extensively metabolized in the liver. Metabolised 
mainly by hydrolysis and n- demethylation. Hydrolysis takes place in the 
liver and it is converted to pethidinic acid. n-demethylation converts it 
into norpethidine. Norpethidine has half the analgesic property but has a 
longer elimination half-life. It gets accumulated in renal failure. It is 
neurotoxic and posses convulsant and hallucinogenic properties due to its 
 
 
34 
 
anticholinergic property which cannot be antagonised with opioid 
antagonists. It is conjugated with glucuronic acid and excreted in urine . It 
is advisable to administer pethidine  with cautious dose adjustments when 
used in patients with hepatic dysfunction in order to avoid its 
accumulation. 
 
 
Figure 10: Metabolism of pethidine 
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Excretion: 
Mean plasma clearance after an i.v injection is 1.06 L/min. 
Elimination half-life of pethidine is approximately 3.5 hours but in case 
of patients with liver cirrhosis and acute viral hepatitis elimination half 
life can be increased upto 7-11hrs. In renal dysfunction patients, the 
elimination half-life of norpethidine is prolonged to 30 hours. In pregnant 
women, the half-life of norpethidine  is  approximately 20.6 hrs. 
Acidification  of urine enhances urinary excretion of pethidine and 
norpethidine. 
Indications: 
1. Short term relief of moderate to severe pain via I.M , S.C, I.V 
bolus, PCA, I.V infusion. 
2. As an anaesthetic adjunct and in obstetric analgesia. 
3. Drug of choice for treatment of shivering in patients undergoing 
surgeries under  regional  and general anaesthesia. Pethidine acts 
via opioid receptors, mainly κ receptor. It decreases the shivering 
threshold twice as much as vasoconstriction threshold. The special 
anti shivering property of pethidine is because of the 
disproportionate decrease in the threshold of shivering. Pethidine 
also acts via κ receptors and decreases shivering. Pethidine is 
considered the gold standard in abolishing shivering in patients 
under anaesthesia. So, numerous studies have been conducted 
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comparing pethidine with other drugs in the prevention and 
treatment of shivering. It is administered at a dose of 0.5mg/kg for 
the treatment of shivering. 
 
Adult Dosage: 
1. Analgesia 
IM / S.C. injection -25 to 100 mg every 3 to 4 hours. 
  IV injection- 25 to 50 mg every 3 to 4 hours. 
Usual recommended dose is about 200 mg/day by the IV route. 
2. Patient-Controlled Analgesia 
For adults, demand doses of 5 mg to a maximum of 20 mg 
pethidine have been given via PCA using a lock out interval of  
about 6 to 20 minutes.  
Contraindications: 
1. Hypersensitivity 
2. Respiratory depression. 
3. Conditions associated with poor respiratory reserve like, acute 
bronchial asthma, severe chronic  bronchitis, severe 
emphysema,  kyphoscoliosis. 
4. Head injury, raised ICP, space occupying lesions. 
5. Cardiac arrythmias, especially Supraventricular tachycardias, 
cor pulmonale. 
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6. Convulsive states such as status epilepticus, tetanus and 
strychnine poisoning. 
7. Pre-eclampsia, eclampsia. 
8. DKA 
9. Liver disease 
        10.  Patients with coagulation disorders. 
Drug interactions: 
1. Enhances CNS depressant effects of barbiturates, butyrophenones,      
chloral hydrate, benzodiazepines. 
2. Phenobarbitone reduces its analgesic effect. 
3. With phenothiazines it causes CNS toxicity and hypotension 
including respiratory depression.  
4. With butyrophenones increased CNS depressant effect can occur. 
5. With monoamine oxidase inhibitors excitation, sweating, rigidity,     
hypertension, delirium, coma can occur. 
6. Paracetamol absorption may be decreased because of delayed 
gastric emptying. 
7. Effects of derivative anticoagulants may be increased. 
Common Adverse reactions: 
In general, dry mouth, weakness, hypersensitivity usually occurs. 
CNS symptoms include sedation, dizziness, lightheadedness, sweating, 
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disorientation, hallucinations and psychosis. Gastrointestinal symptoms 
include nausea, vomiting and constipation. 
Other adverse reactions: 
Accidental   intra-arterial administration can cause vasodilation, 
hypotension, hypertension, tachycardia, bradycardia and gangrene. 
Dermatological reactions like rash, pruritus, urticaria, erythema,  irritation 
and induration,  repeated  intramuscular injections  can cause fibrosis. 
Decreased gastric emptying, increased biliary tract pressure, 
choledochoduodenal sphincter spasm, urinary retention visual and 
auditory hallucinations, agitation, irritability, mania, paranoia, delirium 
and complex partial seizures, vertigo, dizziness, coma, headache, 
convulsions or tremor, respiratory depression, cold clammy skin, 
sweating and pallor. 
Camus and colleagues23 studied the effect of delivering warmed 
intra-venous fluids in order to prevent intra-operative hypothermia.  They 
randomly divided 18 patients undergoing prolonged abdominal surgery 
into two groups of 9 patients each depending on the intra-operative fluid 
management they received. 9 patients received intravenous fluids at room 
temperature while another 9 received warmed intravenous fluids. All 18 
patients were covered with warming blanket at the exposed skin surface. 
They estimated 217 kilojoules decrease in heat loss provided by using 
warmed intravenous fluids. During recovery, only 1 patient who received 
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warmed intravenous fluid shivered while 7 patients who received 
intravenous fluids at room temperature shivered. Thus they noted that 
infusion of warmed intra-venous fluids in combination with blankets to 
cover exposed skin surface in intra-operative period helps to prevent 
intra-operative hypothermia and also reduces incidence of post-operative 
shivering. 
Dyer and Heathcote et al24 conducted a prospective study in 100 
patients to reduce heat loss during trans-urethral resection of prostate 
under spinal anaesthesia by using blankets and used heated 1.5%  glycine 
as bladder irrigation solution. They noted that there was marked decrease 
in incidence of shivering when the patients received both blanket cover 
and heated 1.5% glycine bladder irrigation solution. 
Buggy and Crossley et al25 reviewed thermoregulation, mild peri-
operative hypothermia and post- anaesthetic shivering. They observed 
that shivering occurred in 33% of patients who underwent procedures 
under epidural anaesthesia. They concluded that shivering occurs due to 
impairment of physiologic set points, and combined general-epidural 
anaesthesia has particularly higher risk to cause core hypothermia. 
Doufas et al26 studied the consequences of inadvertent peri-operative 
hypothermia. He noted that peri-operative hypothermia increases the 
incidence of adverse myocardial outcome in high-risk patients and also 
causes increased incidence of blood loss and wound infection of the 
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surgical site in patients who underwent colon surgery, thereby increasing 
duration of hospital stay upto 20%. Hypothermia also affects the body 
immune mechanisms and metabolism of drugs in the body. 
Saito and co-workers27 studied the thermoregulatory effects of 
spinal and epidural anaesthesia during cesarean section delivery. They 
tested a hypothesis that onset of hypothermia was faster under spinal 
anaesthesia as compared to epidural anaesthesia. They randomly assigned 
patients undergoing cesarean delivery under spinal anaesthesia with 2 
milliliters of 0.5% Dibucaine or epidural anaesthesia with 20 milliliters 
2% mepivacaine. Tympanic membrane temperature was measured. They 
failed to confirm the hypothesis but concluded that thermoregulation was 
more impaired with spinal anaesthesia than with epidural. 
Usta B et al28 conducted the study to evaluate the effect of 
dexmedetomidine on shivering in patients undergoing minor surgical 
procedures under spinal anaesthesia with hyperbaric bupivacaine. In that 
60 patients[ASA 1 and 2, aged 18-50yrs] were equally divided  into two 
groups C and D. In that group D received dexmedetomidine and the 
group C received normal saline as placebo. The presence of shivering was 
assessed by a blinded observer after the completion of spinal anesthetic 
injection. In that 3 patients in group D developed shivering whereas in 
group C, 17 patients experienced shivering. The intensity of shivering 
was lesser in patients who received dexmedetomidine when compared to 
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normal saline group C. He concluded that dexmedetomidine infusion in 
the  perioperative  period  significantly reduced the incidence of shivering 
in patients undergoing minor procedures under spinal anaesthesia without 
any significant adverse effects during perioperative period. 
Kelsaka E et al29 conducted a double blinded study to compare the 
effectivenss of ondansetron and meperidine for prevention of shivering in 
patients undergoing spinal anesthesia. In this study, 75 patients were 
randomised into 3 groups. Group O received ondansetron 8mg and Group 
M received meperidine 0.4mg/kg intravenously just before giving spinal 
anesthesia respectively. whereas Group C received normal saline. The 
incidence of shivering and core temperature was recorded in all the three 
groups. Association between the maximum block height and mean rectal 
temperatures of the patients were evaluated.  From the data obtained the 
core temperature was preserved in both the groups who received 
ondansetron and meperidine when compared to control group. Shivering 
was observed in 8% of patients in Group O and M and 36% in Group C. 
The correlation between maximum block height and mean rectal 
temperatures was lost in both the ondansetron and meperidine groups. It 
was concluded that meperidine and ondansetron were equally effective in 
controlling the shivering . 
Asif Iqbal  and co30 conducted a study in which 90 patients  
belong to the age group 20-60yrs, with ASA physical status I and II, 
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planned  for laparoscopic surgery under general anaesthesia were 
randomly allocated in to three groups in which Group P, [n=30] was 
given  pethidine 25mg  Group G, [n=30]  received granisetron 40µg/kg 
and Group S normal saline as a control group  just before induction. 
Temperature probe was kept in the nasopharynx and measured 
throughout the procedure. An investigator, blinded to the treatment group, 
graded postoperative shivering .Prophylaxis was considered as ineffective 
if the shivering grade was greater than 3. Those cases who had shivering 
grades more than 3 received intravenous pethidine 25 mg was as rescue 
medication. The three groups did not differ significantly regarding patient 
characteristics. The incidence of shivering in patients who arrived in the 
recovery room 15 minutes after the surgery were significantly less in 
Group P (7%) and Group G(17%) who received pethidine and granisetron 
respectively  than in Group S (60%). The P values of group P and G 
differ significantly than in Group S (p<0.05).  However, the difference 
between Groups P and G was not statistically significant (p>0.05). So it 
was concluded that prophylactic use of pethidine(25mg) and granisetron 
(40mcg.kg-1)  is effective in preventing  postopearative shivering . 
Kimya et al 31 compared the efficacy of nefopam with meperidine 
for prevention of shivering during  spinal anaesthesia. sixty five patients, 
aged 20-65, with American Society of Anesthesiologists physical Status I 
or II who were scheduled for elective orthopaedic surgery under spinal 
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anesthesia were randomly  allocated into two groups in which group M 
[n=33] received meperidine  0.4mg/kg body weight and Group N,          
[n = 32] received nefopam 0.15 mg/kg as intravenous infusion in 100 ml 
of isotonic saline. All drugs were infused  over 15 min before giving 
spinal anesthesia by a blinded investigator  After giving spinal  
anaesthesia,  the parameters like heart rate, blood pressure, temperature, 
Spo2 were monitored  intraoperatively at 15, 30, and 60 minutes . It was 
observed that the incidence and grades of shivering were similar in both 
the groups so it was concluded that nefopam which is a non opioid 
analgesic can be used as a alternate for meperidine in the prevention of 
shivering under spinal anaesthesia.  
Mohammad Maroof et al32 conducted a placebo-controlled 
double-blind study to assess the effect of epidurally administered 
preservative-free dexmedetomidine on postoperative shivering following 
epidural anesthesia. 60 ASA I & II adult male patients, aged between   
20-40 years; weight range 50-70 kg undergoing elective orthopedic 
surgical procedures of the lower limb were selected. The selected patients 
were randomly divided into group A (Dex) and group B (control) 30 
patients each. Group A received 20 ml of 0.5% bupivacaine (plain) + 
DEX 1 ml [2mcgkg-1]. Group B received 20 ml of 0.5% Bupivacaine 
[plain] + 1 ml normal saline. Routine monitors were applied intra 
operatively. There was a significantly lower incidence of shivering in 
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group A as compared to group B (10% and 36.6% respectively). There 
was no significant difference in the mean arterial pressure (MAP) 
recorded for 6 postoperative hours in either group. Although there was a 
significant decrease in the heart rate (HR) during the first 3 post operative 
hours in groups A, the HR in group B was not significantly changed 
during the first 6 hours post operatively. There was no significant 
difference in the respiratory rate or level of sedation in either group, 
compared to each other and to their pre operative value.  Conclusion of 
the study found that epidural administration of dexmedetomidine 
significantly decreases shivering following epidural anesthesia.        
 Bicer C et al33 conducted a  study to evaluate the efficacy of  
dexmedetomidine  in preventing   postanaesthetic  shivering   by 
comparing with meperidine and  placebo group. About 120 patients (ASA 
I–II) scheduled for elective lower abdominal or orthopaedic surgery of 
about 1–3 h duration were allocated in to 3 groups. Forty patients in each 
group randomly received 1 μg/kg of dexmedetomidine, 0.5 mg/kg of 
meperidine or saline 0.9% as placebo, intravenously (i.v.). Parameters 
like mean arterial pressure, HR, SpO2 and central body temperature were 
measured throughout the procedure. Among the 3 groups,  
postanaesthetic shivering was seen in 22 patients in the placebo group, six 
patients in the dexmedetomidine group and four patients in the 
meperidine group. Conclusion of the study was intraoperative intravenous 
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administration of dexmedetomidine 1μg/kg reduces incidence of 
postanaesthetic shivering as  does meperidine 0.5 mg/kg in patients after 
major surgery.  
  Sukhminderjit Jit Singh Bajwa et al34 conducted  study on 80 
patients, aged 22–59 years,   belongs to  ASA physical status  I and II,  
who underwent laparoscopic surgical procedures under general 
anaesthesia  by using dexmedetomidine infusion in order to find out  its 
effectiveness  in controlling shivering. Patients were allocated randomly 
into two groups: group N (n = 40) and group D (n = 40). Group D were 
administered 1 μg/kg of Dexmedetomidine intravenously, while group N 
received saline during peri-op period. Cardiorespiratory  parameters like 
HR, blood pressure, SpO2 were monitored continuosly  and  recorded 
during the preop, intraop, and postop periods. During the postoperative 
period patients were observed for shivering and recorded as per shivering 
grading scale. Side effects like hypotension, bradycardia were observed, 
recorded, and treated symptomatically. Incidence of shivering in group D 
who received dexmedetomidine intravenously were significantly reduced 
when compared to group N who received normal saline. Around 42.5% 
of patient in group N developed shivering, which was statistically highly 
significant (P = 0.014). Heart rate and mean arterial pressure also showed 
significant variation clinically and statistically in group D patients during 
the postop period (P 0.008 and 0.012). A high incidence of sedation (P = 
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0.000) and dry mouth (P = 0.000)    was   observed in group D, whereas 
the incidence of nausea and vomiting was higher in group (P = 0.011 and 
0.034). Conclusion was dexmedetomidine seems to possess antishivering 
properties and was found to reduce the occurrence of shivering in patients 
undergoing general anesthesia. 
Bozgeyik et al35 conducted a study in which total of 90 patients 
aged 18-60years with American Society of Anesthesiologists physical 
status I-II, undergoing elective arthroscopic surgery under spinal 
anaesthesia  were divided into three groups randomly. After spinal block, 
100 mg tramadol in 100 ml saline was applied in group T (n = 30) and 0.5 
μg/kg dexmedetomidine in 100 ml saline was applied in group D (n = 30) 
and 100 ml saline was administered in group P- (n = 30) in 10 min. The 
hemodynamics, oxygen saturation, tympanic temperature, shivering and 
sedation scores were evaluated and recorded intraoperatively and 45 min 
after a postoperative period. Results: In group T and D, shivering scores 
were significantly lower when compared with group P in the 
intraoperative 20th min (P = 0.01). Sedation scores in group D were 
significantly higher than the baseline values (P = 0.03) and values in 
group T and P (P = 0.04). Conclusion of the study was preemptive 
tramadol and dexmedetomidine are effective in preventing the shivering 
under SA. In addition, dexmedetomidine was superior in increasing the 
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level of sedation which is sufficient to prevent the anxiety without any 
adverse effects. 
Geetha mittal  and co36  did a study in 60 patients of ASA 
physical status 1 and 2  in which Both dexmedetomidine (0.5 μg/kg) and 
tramadol (0.5 mg/kg) are effective in treating patients with post-spinal 
anaesthesia shivering, but time taken for complete cessation of shivering  
was shorter with  dexmedetomidine  as compared to tramadol, the 
difference being statistically significant. Furthermore, dexmedetomidine 
causes fewer adverse effects like nausea and vomiting. Sedation caused 
by dexmedetomidine provides additional comfort to the patient.  
Semra Karaman37 and  co conducted a  placebo-controlled, 
randomized study   to evaluate the efficacy of dexmedetomidine in 
preventing  postoperative shivering. In that  Sixty patients who underwent 
gynecologic laparoscopic surgery were assigned randomly to 2 groups 
and  administered  dexmedetomidine as a loading of 1 µg kg–1 for 10 
min followed by maintenance infusion of 0.5 µg kg/hr in 1 group  and  
normal saline infusion in another group. Postoperative shivering was 
observed in 14 patients in normal saline group when compared to only 3 
patients who  received dexmedetomidine. The sedation scores were on 
the higher side in the dexmedetomidine group than in the saline group 
which made the patient comfortable during surgical procedure 
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Mohamed Hamdy Ellakany38 et al conducted a study in 75 
patients who underwent lower abdominal surgeries under spinal 
anaesthesia. Intrathecal dexmedetomidine and meperidine lowered the 
incidence of shivering and increased duration of sensory and motor block 
during lower abdominal operations. Intrathecal  meperidine  caused more 
pruritus, nausea and vomiting than  intrathecal dexmedetomidine.   
  Hazem el syed and co39 conducted a randomized control study in 
which 80  patients who were scheduled for elective TURP under spinal 
anaesthesia were randomly allocated  into two groups in which one group 
received 0.5 ml of normal saline along with 2.5 ml of 0.5 percent 
bupivacaine and the another group received 10 µg of dexmedetomidine 
along with 2.5 ml of 0.5% bupivacaine  and  found that  incidence of 
shivering was significantly reduced in the dexmedetomidine group  when 
compared with normal saline group with occurrence of tolerable side 
effects like hypotension and bradycardia. 
Blain Easley et al 40 conducted a study in which twenty-four children 
aged 7 to 16 years who underwent surgical procedures under general 
anaesthesia along with regional technique were allocated  into the study.  
Those children who fulfilled the inclusion criteria   (i) shivering, (ii) 
successful extubation, and (iii) no other complaint/indication of pain  were  
given  a single intravenous bolus dose of dexmedetomidine (0.5 µg/kg) over 
3-5 min and observed. Following the completion of drug administration, 
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shivering activity was recorded every minute (up to 10 min) with any 
adverse effects or complaints were treated accordingly. All children who 
received dexmedetomidine had a cessation of shivering behavior within 5 
min at the end of dexmedetomidine administration. No significant adverse 
effects and shivering recurrence were observed. 
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MATERIALS AND METHODS 
Ethics Committee Approval  
The Institutional Ethics committee reviewed the application and 
granted ethical approval for the study. 
Study Design 
A  Single centre, cross-sectional and comparative study design was 
used. 
Study Sample: 80 
Study Setting 
Government  Kilpauk  Medical College   
Period of Study 
The work was carried out from March, 2015 to July, 2015.  
Inclusion Criteria 
1. Patients undergoing elective lower abdominal surgeries under 
spinal anesthesia. 
2. Patients between the age group of 18 to 60yrs 
3. American Society of Anesthesiologists physical status I or II 
Exclusion criteria: 
1. Patients not willing for the study 
2. ASA III & ASA IV 
3. Pregnant women 
4. Patients  who are known allergic to study drugs 
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5. Contraindications  to spinal anaesthesia 
6. Duration of surgery more than 2 hours 
7. Patients with thyroid disease, Addisons disease,  Parkinsons 
disease,     Raynauds syndrome, cardiopulmonary, liver and renal 
diseases. History of convulsions/epilepsy, bronchial asthma, patient 
with enlarged prostate or urinary retention problems. 
8. Any need for blood transfusion during intraoperative period 
9. Initial body temperature <36.0 or >37.5 .c 
10. Use of sedative hypnotic agents, antidepressant therapy like 
monoamine oxidase inhibitors, selective serotonin reuptake 
inhibitors, vasodilators,  benzodiazepines. 
Consent 
An informed consent was obtained from participants after 
explaining the study procedure to them. 
Materials: 
The following equipments, drugs and monitors were kept ready for 
the conduct of anaesthesia 
Drugs: 
1. Inj.Dexmedetomidine 0.5µg/kg 
2. Inj.Meperidine 0.5mg/kg 
3. Inj.Ondansetron 8mg 
4. 3.5 ml of 0.5% hyperbaric bupivacaine 
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5. 2ml of 2% lignocaine for local infiltration 
Monitors: 
A multi parameter monitor with following was made available  
1. Electrocardiography 
2. Non-invasive Blood Pressure 
3. Pulse Oximetry 
4. Thermometer to  measure axillary temperature 
Methods: 
Screening of patients 
Before data collection began, informed written consent was 
obtained from all patients after explaining the procedure. All patients 
were interviewed during their first visit of the study and their medical 
history was obtained using a proforma. Details of the history included.  
Method of collection of data     
Eighty  patients, aged (18-60years), assessed under ASA physical 
status I or II scheduled for elective lower abdominal surgical surgeries 
under spinal anesthesia will be enrolled in the study.  
The patients  were seen preoperatively day before surgery. Patient 
was adviced  nil per oral for 8 hours duration and antacid prophylaxis 
were given before shifting the patient to theatre. The operating room 
temperature will be maintained at 23°C to 25°C (measured by a wall 
thermometer).  
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The anaesthesia machine was checked before shifting the patients, 
all the airway gadgets like laryngoscope, endotracheal  tube, oral airway 
and suction were kept ready. Emergency drugs like adrenaline, atropine, 
ephedrine were kept ready. Irrigation and I.V fluids administered to the 
patients were kept at room temperature and given without inline 
warming. All patients will be covered with one layer of surgical drapes 
over the chest, thighs, and calves during the operation. No other warming 
device will be used. A core temperature below 36°C will be considered 
hypothermia.  
Patients were shifted to the operation theatre, monitors were 
connected (pulse oximetry, electrocardiography, temperature and non-
invasive arterial blood pressure monitoring), intravenous (IV) access was 
secured with 18-G cannula and patients were preloaded with RL at 
10ml/kg over 15 mins before performing spinal anesthesia. Under strict 
aseptic precaution, patient in right lateral position subarachnoid block 
will be instituted at  L3-4  interspaces by  using a 25G  Quincke spinal 
needle and  3.5 ml of hyperbaric bupivacaine will be injected . The 
patients will be randomly allotted to one of two groups using a computer-
generated random list. Group D will receive dexmedetomidine (n=40) 
and Group M will receive meperidine (n=40). Just after giving  
intrathecal injection, all drugs will be infused intravenously. Group D will 
be given an I.V bolus  of dexmedetomidine 0.5 mcg per kg in 100ml 
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normal saline over a period of  10 minutes. Group M will receive 0.5mg 
per kg meperidine in 100 ml normal saline intravenously. All the patients 
will receive Supplemental oxygen via face mask during surgery. Patients 
were monitored throughout the procedure and post operatively  for  24 
hours. 
Motor block is assessed by using a Modified Bromage scale  
Grade 0 - no motor block; 
Grade 1 - Inability to raise extended leg, able to move 
knees and feet 
Grade 2 - inability to raise extended leg and  move knees, 
able to move feet  
Grade 3 - Complete block of motor limb 
Sensory block is assessed by the pinprick test.  
Shivering is graded on a scale similar to that validated by Tsai and Chu  
0 = No shivering 
1 = Piloerection or peripheral vasoconstriction without  
  visible shivering 
2 = Muscular activity involving  only one muscle group,  
3 =  Muscular activity involving  more than one muscle  
group but not generalized 
4 = Shivering involving the whole body. 
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Sedation score will be assessed by using  Ramsay  sedation scale 
1 - Patient is anxious and agitated or restless 
2 - Patient is cooperative, oriented and tranquil 
3 - Patient responds to commands only, 
4 - Patient exhibits brisk response to light glabellar tap or 
loud auditory stimulus 
5 - Patient exhibits  sluggish response to light glabellar 
tap or loud auditory stimulus 
6 - Patient exhibits no response 
           Patient’s heart rate, blood pressure, oxygen saturation and 
temperature will be recorded at every 5 minutes till end of surgery. The 
incidence and severity of shivering will be recorded at every 5min during 
the surgery.  If the patient’s heart rate falls below 50 bpm, 0.6 mg of 
atropine was administered intravenously. Hypotension is defined as a 
decrease in the mean arterial pressure (MAP) of  more than 20 % from 
baseline. Hypotension is treated with 6 mg  Ephedrine via I.V bolus and 
then with further  I.V infusion of lactated Ringer’s solution as required. If 
patients develop nausea and vomiting, inj.ondansentron 8mg IV was 
administered. Patients who developed shivering during the study period 
were given Inj. dexmedetomidine 0.3mics/kg IV over 5 min as a rescue 
drug.  
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Statistical Analysis  
The patients were divided into two groups by meperidine and 
dexmedetomidine groups.  Descriptive statistics was done for all data and 
were reported in terms of mean values and percentages. Suitable 
statistical tests of comparison were done. Continuous variables were 
analysed with the unpaired t test. Categorical variables were analysed 
with Fisher Exact Test. Statistical significance was taken as P < 0.05. The 
data was analysed  using SPSS version 16 and Microsoft Excel 2007. 
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RESULTS 
80 patients included in the study (40 each  in dexmedetomidine and 
meperidine group) 
AGE 
 
Figure 11 
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Table 2 : 
Age Distribution Group M % Group D % 
≤ 20 years 3 7.50 3 7.50 
21-40 years 19 47.50 31 77.50 
41-60 years 18 45.00 6 15.00 
> 60 Years 0 0.00 0 0.00 
Total 40 100 40 100 
 
Table 3 : 
Age Distribution Group M Group D 
N 40 40 
Mean 38.28 33.28 
SD 10.63 9.50 
P value Unpaired t Test 0.2951 
 
Majority of the meperidine group patients belonged to the 21-40 
years age group (n=19, 47.50%) with a mean age of 38.28years. In the 
dexmedetomidine group patients, majority belonged to the same age 
group as meperidine group (n=31, 77.50%) with a mean age of 33.28 
years. The association between the intervention groups and age 
distribution is considered to be not statistically significant since p > 0.05 
as per unpaired t test. 
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GENDER 
Figure 12 : 
Table 4 : 
Gender 
Distribution Group M % Group D % 
Male 22 55.00 20 50.00 
Female 18 45.00 20 50.00 
Total 40 100 40 100 
P value Fishers Exact Test 0.6626 
 
Majority of the meperidine group patients belonged to the male 
gender group (n=22, 45%). In the dexmedetomidine group patients, 
majority belonged to the male gender group (n=20, 50%). The association 
between the intervention groups and gender distribution is considered to 
be not statistically significant since p > 0.05 as per fishers exact test. 
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WEIGHT 
 
Figure 13 :  
Table 5 : 
Weight Distribution Group M % Group D % 
31-50 kg 7 17.50 5 12.50 
51-70 kg 26 65.00 28 70.00 
> 70 kg 7 17.50 7 17.50 
Total 40 100 40 100 
Table 6 :  
Weight Distribution Group M Group D 
N 40 40 
Mean 59.38 61.25 
SD 10.73 9.90 
P value Unpaired t Test 0.4192 
Majority of the meperidine group patients belonged to the 51.00 kg 
weight group (n=26, 65%) with a mean weight of 59.38 kg. In the 
dexmedetomidine group patients, majority belonged to the same weight 
group as meperidine group (n=28, 70%) with a mean weight of 61.25 kg. 
The association between the intervention groups and weight distribution is 
considered to be not statistically significant since p > 0.05 as per unpaired t 
test. 
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HEIGHT 
 
Figure 14 : 
Table 7: 
Table 8: 
Majority of the meperidine group patients belonged to 1.61to1.70 
meters height group (n=23, 57.50%) with a mean height of 1.61 meters. 
In the dexmedetomidine group patients, majority belonged to the same 
height group as meperidine group (n=21, 52.50%) with a mean height of 
1.62 meters. The association between the intervention groups and height 
distribution is considered to be not statistically significant since p > 0.05 
as per unpaired t test. 
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Height Distribution Group M % Group D % 
1.51-1.60 mts 17 42.50 19 47.50 
1.61-1.70 mts 23 57.50 21 52.50 
Total 40 100 40 100 
Height Distribution Group M Group D 
N 40 40 
Mean 1.61 1.62 
SD 0.07 0.08 
P value Unpaired t Test 0.6314 
 
 
62 
 
ASA CLASSIFICATION 
 
Figure 15 : 
Table 9 : 
ASA Classification Group M % Group D % 
ASA 1 31 77.50 33 82.50 
ASA 2 9 22.50 7 17.50 
Total 40 100 40 100 
P value Fishers Exact Test 0.5915 
 
Majority of the meperidine group patients belonged to the ASA 1 
group (n=31, 77.50%). In the dexmedetomidine group patients, majority 
belonged to the ASA 1 group (n=33, 82.50%). The association between 
the intervention groups and ASA classification is considered to be not 
statistically significant since p > 0.05 as per Fisher exact test. 
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HEART RATE 
 
Figure 16 : 
Table 10 : 
 
Table 11 : 
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Heart Rate Baseline 5 min 10min 15 min 20 min 25 min 30 min 
Group M 
N 40 40 40 40 40 40 40 
Mean 84.28 84.95 85.63 84.85 84.95 82.38 79.65 
SD 6.71 8.92 9.92 10.85 11.21 10.98 10.34 
Group D 
N 40 40 40 40 40 40 40 
Mean 82.63 88.23 92.23 86.85 82.80 81.43 78.85 
SD 5.66 8.49 8.48 12.40 12.85 10.35 8.92 
P value Unpaired t Test 0.2381 0.0965 0.1120 0.4450 0.4276 0.6916 0.7121 
Heart Rate 35min 40min 45 min 50 min 55 min 60min 
Group M 
N 40 40 40 40 40 40 
Mean 77.73 77.60 76.65 74.88 82.63 88.58 
SD 8.92 8.21 6.92 7.20 5.66 8.68 
Group D 
N 40 40 40 40 40 40 
Mean 77.33 75.98 75.70 74.45 84.95 85.33 
SD 7.92 6.91 6.51 6.41 8.92 10.74 
P value Unpaired t Test 0.8326 0.3413 0.5289 0.7811 0.1685 0.1408 
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Figure 17 :  
 
Table 12 : 
Majority of the meperidine group patients had mean heart rate 
ranging from 84.28 to 74.45 between baseline and 110 minutes 
intraoperatively. Similarly majority of the dexmedetomidine Group patients 
had mean heart rate ranging from 82.63 and 74.00 between baseline and 110 
minutes intraoperatively.  The association between the intervention groups 
and mean heart rate is considered to be not statistically significant since p > 
0.05 as per 2 tail unpaired t test. 
Heart Rate 
65 
min 
70 
min 
75 min 80 min 85 min 90 min 95 min 100 min 
110 
min 
G
ro
up
 M
 
N 40 40 40 40 40 40 40 40 40 
M
ea
n 
93.38 89.25 84.28 81.43 78.85 77.33 75.98 75.70 74.45 
SD 8.83 8.31 10.22 9.02 8.92 7.92 6.91 6.51 6.41 
G
ro
up
 D
 
N 40 40 40 40 40 40 40 40 40 
M
ea
n 
84.85 84.95 82.38 79.65 77.73 77.60 76.65 74.88 74.00 
SD 10.85 11.21 10.98 10.34 8.92 8.21 6.92 7.20 10.34 
P 
va
lu
e 
U
np
ai
re
d 
t T
es
t 
0.3322 0.2452 0.4255 0.4159 0.5742 0.8793 0.6637 0.5922 0.1488 
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MEAN ARTERIAL PRESSURE 
 
Figure : 18 
Table 13 : 
Mean Arterial 
Pressure Baseline 5 min 10min 15 min 20 min 25 min 
30 
min 
Group 
M 
N 40 40 40 40 40 40 40 
Mean 78.40 74.00 71.50 70.70 71.78 73.28 71.73 
SD 6.32 5.50 6.66 6.46 5.78 6.00 5.42 
Group 
D 
N 40 40 40 40 40 40 40 
Mean 84.48 74.13 73.08 71.60 71.48 73.13 72.08 
SD 8.98 5.14 4.55 5.49 6.10 6.27 5.99 
P value Unpaired t 
Test 0.1318 0.9166 0.2212 0.5039 0.8219 0.9132 0.7847 
 
Table 14 : 
Mean Arterial Pressure 35min 40min 45 min 50 min 55 min 60min 
Group M 
N 40 40 40 40 40 40 
Mean 71.38 73.75 74.40 76.88 74.63 74.00 
SD 6.33 5.78 5.57 5.81 6.77 5.50 
Group D 
N 40 40 40 40 40 40 
Mean 71.35 73.88 74.28 77.25 75.65 74.10 
SD 6.17 5.29 5.67 5.51 6.26 5.21 
P value Unpaired t Test 0.9858 0.9199 0.9210 0.7678 0.4840 0.9337 
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Figure 19 :  
Table 15 : 
Majority of the meperidine group patients had mean arterial pressure 
ranging from 70.70 mm Hg to 76.88 mm Hg between  baseline and  110 
minutes intraoperatively. Similarly majority of the dexmedetomidine group 
patients had mean arterial pressure ranging from 72.08 mm Hg to 84.48 mm 
Hg between  baseline and 110 minutes intraoperatively. The association 
between the intervention groups and mean arterial pressure is considered to be 
not statistically significant since p > 0.05 as per 2 tail unpaired t test. 
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Mean Arterial 
Pressure 
65 
min 
70 
min 
75 
min 
80 
min 
85 
min 
90min 95 min 
100 
min 
110 
min 
Group  
M 
N 40 40 40 40 40 40 40 40 40 
Mean 72.95 72.00 71.63 72.73 71.48 71.38 73.75 74.40 74.63 
SD 6.12 5.18 5.56 5.93 5.54 6.33 5.78 5.57 6.77 
Group 
D 
N 40 40 40 40 40 40 40 40 40 
Mean 73.30 72.08 72.23 73.20 72.58 71.43 74.18 74.93 74.30 
SD 4.60 5.29 5.50 6.02 4.83 5.92 5.29 5.42 5.56 
P value Unpaired t 
Test 0.7732 0.9491 0.6290 0.7231 0.3467 0.9710 0.7323 0.6704 0.0572 
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TEMPERATURE 
 
Figure 20 : 
Table 16 : 
Temperature Baseline 10min 20 min 30min 40 min 50 min 60min 
Group 
M 
N 40 40 40 40 40 40 40 
Mean 36.12 35.92 35.90 35.96 35.99 36.02 36.04 
SD 0.22 0.18 0.15 0.14 0.13 0.15 0.14 
Group 
D 
N 40 40 40 40 40 40 40 
Mean 36.09 35.91 35.89 35.96 35.98 36.01 36.03 
SD 0.21 0.16 0.14 0.14 0.12 0.14 0.14 
P value Unpaired t 
Test 0.5331 0.8443 0.8762 0.8736 0.7171 0.8192 0.7516 
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Table 17 :  
Temperature 70min 80min 90 min 100 min 110 min 
Group M 
N 40 40 40 40 40 
Mean 36.03 36.03 36.02 36.03 36.09 
SD 0.14 0.14 0.13 0.15 0.20 
Group D 
N 40 40 40 40 40 
Mean 36.02 36.02 36.01 36.02 36.09 
SD 0.14 0.14 0.12 0.14 0.21 
P value Unpaired t Test 0.6339 0.6339 0.9276 0.7626 0.9122 
 
Majority of the meperidine group patients had mean temperature 
ranging from 36.12 ⁰C and 35.90 ⁰C between baseline and 110 minutes 
intraoperatively. Similarly majority of the dexmedetomidine group 
patients had mean temperature ranging from 35.89 ⁰C and 36.09 ⁰C 
between baseline and 110 minutes intraoperatively. The association 
between the intervention groups and mean temperature is considered to 
be not statistically significant since p > 0.05 as per 2 tail unpaired t test. 
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SHIVERING GRADE 
 
Figure 21 : 
Table 18 : 
Shivering Grade 5 min 10min 15 min 20 min 25 min 30 min 
Group M 
N 40 40 40 40 40 40 
Mean 0.00 0.00 0.00 0.05 0.15 0.25 
SD 0.00 0.00 0.00 0.32 0.66 0.78 
Group D 
N 40 40 40 40 39 40 
Mean 0.00 0.00 0.00 0.00 0.08 0.13 
SD 0.00 0.00 0.00 0.00 0.48 0.56 
P value Unpaired t Test NA NA NA 0.3235 0.5756 0.4125 
Table 19 : 
Shivering Grade 35min 40min 45 min 50 min 55 min 60min 
Grou
p M 
N 40 40 40 40 40 40 
Mean 0.20 0.18 0.20 0.13 0.10 0.05 
SD 0.72 0.64 0.72 0.56 0.44 0.32 
Group 
D 
N 40 40 40 40 40 40 
Mean 0.18 0.15 0.13 0.00 0.00 0.00 
SD 0.64 0.66 0.56 0.00 0.00 0.00 
P value Unpaired t Test 0.8700 0.8637 0.6064 0.1684 0.1599 0.3235 
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Figure 22 : 
Table 20 : 
Shivering Grade 65 min 70 min 75 min 80 min 85 min 90 min 95 min 100 min 110 min 
Group M 
N 40 40 40 40 40 40 40 40 40 
Mean 0.05 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
SD 0.32 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
Group D 
N 40 40 40 40 40 40 40 40 40 
Mean 0.05 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
SD 0.32 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
P value Unpaired t Test 1.00 NA NA NA NA NA NA NA NA 
 
Majority of the meperidine group patients had mean shivering grade ranging 
from 0.00 to 0.05 between baseline and 65 minutes intraoperatively. Similarly 
majority of the dexmedetomidine  group patients had mean shivering grade ranging 
from 0.00 and 0.05 between baseline and 65 minutes intraoperatively. The association 
between the intervention groups and mean shivering is considered to be not 
statistically significant since p > 0.05 as per 2 tail unpaired t test.  
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SEDATION SCORE 
 
Figure 23 : 
Table 21:  
Sedation Score Pre- op 10min 20 min 30 min 40 min 50 min 60min 
Group M 
N 40 40 40 40 40 40 40 
Mean 0.00 2.00 2.00 2.00 2.03 2.03 2.05 
SD 0.00 0.00 0.00 0.00 0.16 0.16 0.22 
Group D 
N 40 40 40 40 40 40 40 
Mean 0.00 2.00 2.98 2.98 3.00 3.00 2.98 
SD 0.00 0.00 0.16 0.16 0.00 0.00 0.16 
P value Unpaired t Test 
  
0.0000 0.0000 0.0000 0.0000 0.0000 
 
  
0.00
0.50
1.00
1.50
2.00
2.50
3.00
3.50
Pre- op 10min 20 min 30 min 40 min 50 min 60min 70 min 80 min 90 min 100 
min
110 
min
M
ea
n 
Sc
or
e
Sedation Score
Group M Group D
 
 
72 
 
Table 22 : 
Sedation Score 70 min 80 min 90 min 100 min 110 min 
Group 
M 
N 40 40 40 40 40 
Mean 2.05 2.08 2.08 2.08 2.05 
SD 0.22 0.27 0.27 0.27 0.22 
Group 
D 
N 40 40 40 40 40 
Mean 2.93 2.93 2.95 2.95 2.15 
SD 0.27 0.27 0.22 0.22 0.36 
P value Unpaired t Test 0.0000 0.0000 0.0000 0.0000 0.1404 
 
The association between the intervention groups and mean sedation 
score is considered to be statistically significant from 20 and 100 minutes 
since p < 0.05 as per unpaired t test. In patients belonging to meperidine 
intervention group, the mean sedation score is decreased to an average of 
1.84 points in comparison with patients belonging to dexmedetomidine  
intervention group in whom the mean sedation score  is an average of  
2.67 points. This indicates that there is a true difference among 
intervention groups and the difference is significant with a p-value of 
0.0000 according to unpaired t-test.  
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RESPIRATORY RATE 
 
 
Figure 24 :  
 
Table 23 : 
Respiratory Rate Pre- op 10min 20 min 30 min 40 min 50 min 60min 
Group M 
N 40 40 40 40 40 40 40 
Mean 12.75 12.75 12.73 12.63 12.38 12.38 12.38 
SD 0.84 0.84 0.82 0.77 0.93 0.93 0.84 
Group D 
N 40 40 40 40 40 40 40 
Mean 12.53 12.18 12.23 12.23 12.28 12.25 12.23 
SD 0.82 0.55 0.58 0.58 0.68 0.63 0.58 
P value Unpaired t Test 0.2279 0.1177 0.2223 0.5107 0.5832 0.4824 0.3542 
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Table 24 : 
Respiratory Rate 70 min 80 min 90 min 100 min 110 min 
Group 
M 
N 40 40 40 40 40 
Mean 12.48 12.58 12.68 12.68 12.75 
SD 0.96 0.75 0.80 0.76 0.84 
Group 
D 
N 40 40 40 40 40 
Mean 12.20 12.25 12.23 12.25 12.25 
SD 0.56 0.63 0.58 0.63 0.63 
P value Unpaired t 
Test 0.1234 0.1388 0.3351 0.7183 0.4536 
 
Majority of the meperidine Group patients had mean respiratory 
rate ranging from 12.38 breath per minute  12.75 breath per minute 
between baseline and 110 minutes  intraoperatively. Similarly majority of 
the dexmedetomidine  group patients had mean respiratory rate ranging 
from 12.18 breath per minute to 12.53 breath per minute between 
baseline and 110 minutes intraoperatively. The association between the 
intervention groups  and respiratory rate is not statistically significant  
since p > 0.05 as per 2 tail unpaired t test. 
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PERIPHERAL CAPILLARY OXYGEN SATURATION 
 
Figure 25 : 
Table 25 : 
Peripheral 
Capillary Oxygen 
Saturation 
Baseline 5 min 10min 15 min 20 min 25 min 30 min 
Group 
M 
N 38 40 37 20 27 38 33 
Mean 99.92 100.00 99.95 99.05 99.56 99.89 99.85 
SD 0.27 0.00 0.23 0.83 0.75 0.45 0.51 
Group 
D 
N 40 35 38 40 35 29 27 
Mean 99.73 99.97 99.97 100.00 100.00 99.38 99.59 
SD 0.51 0.17 0.16 0.00 0.00 0.78 0.75 
P value Unpaired t 
Test 0.0360 0.3244 0.5483 0.0001 0.0049 0.0027 0.1366 
 
Table 26 : 
Peripheral 
Capillary Oxygen 
Saturation 
35min 40min 45 min 50 min 55 min 60min 
Group 
M 
N 26 37 39 38 34 26 
Mean 99.77 99.68 98.87 98.84 99.85 99.81 
SD 0.71 0.75 1.36 1.37 0.70 0.80 
Group 
D 
N 38 34 27 40 39 40 
Mean 99.97 99.94 99.93 99.95 98.87 100.00 
SD 0.16 0.24 0.27 0.22 1.36 0.00 
P value Unpaired t 
Test 0.1609 0.6464 0.2788 0.1636 0.3112 0.2323 
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Figure 26 : 
Table 27 :  
Peripheral Capillary 
Oxygen Saturation 
65 
min 
70 
min 
75 
min 
80 
min 
85 
min 
90 
min 
95 
min 
100 
min 
110 
min 
Group M 
N 32 32 24 32 40 40 36 38 40 
Mean 99.00 
99.6
6 
99.2
1 
99.5
3 
99.4
8 
99.4
8 
99.9
7 
99.9
7 
99.8
8 
SD 1.19 0.70 0.72 0.84 0.85 1.11 0.17 0.16 0.40 
Group D 
N 39 33 32 40 40 40 35 39 40 
Mean 100.00 
99.4
2 
99.5
3 
99.8
8 
100.
00 
99.9
0 
99.9
7 
99.9
7 
100.
00 
SD 0.00 0.75 0.84 0.52 0.00 0.50 0.17 0.16 0.00 
P value Unpaired t Test 0.4455 
0.20
24 
0.12
88 
0.54
83 
0.66
13 
0.23
12 
0.98
42 
0.98
54 
0.05
77 
Majority of the meperidine group patients had mean peripheral 
capillary oxygen saturation ranging from 99.05% to 100% between 
baseline and 110 minutes intraoperatively. Similarly majority of the 
dexmedetomidine group patients had mean respiratory rate ranging from 
99.38%  to 100% between baseline and 110 minutes intraoperatively. The 
association between the intervention groups and mean mean peripheral 
capillary oxygen saturation is considered to be not statistically significant 
since p > 0.05 as per 2 tail unpaired t test. 
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                           NAUSEA/ VOMITING 
 
Figure 27 :  
Table 28 : 
Nausea/Vomiting Group M % Group D % 
No 34 85.00 38 95.00 
Yes 6 15.00 2 5.00 
Total 40 100 40 100 
P value Fishers Exact Test 0.9999 
  
In meperidine group, 6 patients had nausea/vomiting (n=6, 15%). 
In the dexmedetomidine group, only 2 had nausea/vomiting (n=2, 5%). 
The association between the intervention groups and incidence of 
nausea/vomiting is considered to be not statistically significant since p > 
0.05 as per Fisher’s exact test. 
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RESCUE DRUG 
 
Figure 28 : 
Table 29 :  
Rescue Meperidine Dexmedetomidine 
Yes 4 3 
No 36 37 
 
In this study, 4 patients in meperidine group and 3 patients in 
dexmedetomidine group required rescue drug.  
  
20% 40% 60% 80% 100%
Meperidine
Dexmedetomidine
Rescue drug No
Rescue drug Yes
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HYPOTENSION 
 
Figure 29 : 
Table 30 : 
Dexmedetomidine Meperidine 
 
p value 
3 0 
0.067 
 
In this study, 3 patients from dexmedetomidine group had a fall in 
systolic blood pressure to less than 90 mm Hg during the study period. 
Patients in meperidine group did not have any hypotension. The p value 
for this is 0.067 which is not significant. 
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BRADYCARDIA 
  
 
Figure 30 : 
Table 31 : 
 
In this study, no patient from meperidine group had bradycardia 
but three patients from dexmedetomidine group had a fall in heart rate of 
less than 50 beats per minute. The p value is 0.067 which is not 
statistically significant.  
0 0.5 1 1.5 2 2.5 3
Dexmedetomidine
Meperidine
Bradycardia
Dexmedetomidine
Meperidine
Dexmedetomidine Meperidine 
 
p value 
3 0 
0.067 
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DISCUSSION 
Shivering continues to be a common problem faced by the 
anaesthesiologist  during intra operative and post operative periods 
following spinal anaesthesia. Unfortunately, there is no gold standard 
drug or definitive strategy drawn in management of this commonly 
encountered problem. Multiple  neurotransmitter pathways  have been 
found to involve in  shivering   and most of the drugs like opioids 
(pethidine & tramadol), doxapram, ketanserin,  propofol, ketamine, 
clonidine and  nefopam used  acts on these pathways to control shivering. 
However, adverse effects such as hypotension, sedation, respiratory 
depression, nausea and vomiting limit their use.  
So, the search for an ideal anti-shivering agent with fewer side effects  is 
continuing. Many  studies  were  available  regarding  treatment of  
intraoperative shivering  but only few studies were available for 
prevention of shivering by prophylactic administration  of  antishivering  
agents.  
Hence, this study was undertaken to study and compare the 
effectiveness of dexmedetomidine and meperidine in the prevention of 
intraoperative shivering in patients undergoing elective lower abdominal 
surgeries under spinal anesthesia. Also in this study, we compared the 
side effect profile of these drugs. 
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In our study, age group of patients included was between 18 to 
60yrs. Mean age in meperidine group was 38.28yrs and in 
dexmedetomidine group was 33.28yrs. Age group of patients included in 
the study by Usta et al were between 18 to 50yrs. Mean age in 
Dexmedetomidine group was 36 yrs and in control group it was 37yrs. 
Age group of patients included in the study by Geetha et al was 
between 18 and 65 yrs. Mean age in dexmedetomidine group was 38yrs 
and in tramadol group was 37 yrs. There was no significant difference 
between the age group selected in our study, Usta et al and Geetha et al. 
Hence selection bias was excluded. 
In our study,  male : female ratio in meperidine group is 55% : 45% 
and in dexmedetomidine group it is 50% each. Usta et al in his study 
showed the male : female ratio as 75% : 25% in dexmedetomidine group 
and 70% : 30% in control group. Geetha et al in her study showed the 
male : female ratio as 60% : 40% and  52% : 48% in tramadol group. 
There was no statistically significant difference between gender selection 
in our study, Usta et al and Geetha et al. This strengthens our study. 
In our study, mean weight of patients in meperidine group was 59.38 kg 
and in dexmedetomidine group, it was 61.25 kg. Mean weight of the 
patient in the study by Usta et al was 80kg both in dexmedetomidine and 
control group (normal saline). There was no statistically significant 
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difference the weight selection between the groups in our study and Usta 
et al. Hence selection bias was excluded.  
In our study, mean height of patients in meperidine group was 1.61 
meters and in dexmedetomidine group it was 1.62 meter. Mean height of 
the patient in the study by Usta et al was 1.70 metre in dexmedetomidine 
and 1.73 meter in control group (normal saline). There was no 
statistically significant difference the height selection between the groups 
in our study and Usta et al. Hence, selection bias was excluded.  
In our study, majority of the dexmedetomidine group patients belonged to 
the ASA 1 group (n=33, 82.50%). In the meperidine group patients, 
majority belonged to the ASA 1 group (n=31, 77.50%).  In the study by 
Fern and Misiran showed that dexmedetomidine group was shared 
equally between ASA 1 and ASA 2 groups (50% each) and majority in 
meperidine group belonged to ASA 2 group (75%). The association 
between the intervention groups and ASA classification is considered to 
be not statistically significant both in our study and Fern & Misiran study. 
Few studies have attempted to study the correlation between heart 
rate, mean arterial pressure, temperature, shivering grade, respiratory rate, 
oxygen saturation and side effect profile of tramadol, normal saline and 
other drugs with dexmedetomidine. But there are no studies comparing 
the effectiveness between meperidine and dexmedetomidine in 
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preventing  shivering perioperatively in lower abdominal surgeries under 
spinal anaesthesia. 
In our study, majority of the meperidine Group patients had mean 
heart rate ranging from 84.28 to 74.45 between baseline and 110 minutes 
intraoperatively. Similarly majority of the dexmedetomidine Group 
patients had mean heart rate ranging from 82.63 and 74.00 between 
baseline and 110 minutes intraoperatively.  In the study by Usta et al, 
majority of the normal saline group had mean heart rate ranging from 88 
to 85 bpm and in dexmedetomidine group it was ranging from 90 to 70 
bpm between baseline and 110min intra operatively. The association 
between the intervention groups and mean heart rate was considered to be 
not statistically significant in our study and in the study by Usta et al it is 
statistically significant as the comparison in this study was between 
normal saline and dexmedetomidine.    
In our study, majority of the meperidine Group patients had mean 
arterial pressure at baseline of 78.40 mm Hg and at 110 minutes of 74.63 
mm Hg intraoperatively respectively. Similarly majority of the 
dexmedetomidine Group patients had mean arterial pressure at baseline 
of 84.48 mm Hg and  at 110 minutes of 74.30 mm Hg intraoperatively 
respectively.  In the study by Usta et al, majority of the normal saline 
group had mean arterial pressure ranging from 90 to 88 mm of Hg and in 
dexmedetomidine group it was ranging from 90 to 78 mm of Hg between 
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baseline and post operatively respectively. The association between the 
intervention groups and mean arterial pressure was considered to be not 
statistically significant both at baseline and post operatively in our study 
but p value was significant when mean arterial pressure was compared 
pre and post op in dexmedetomidine group.  
In the study by Usta et al it is statistically significant only when 
mean arterial pressure in patients treated with the normal saline group and 
dexmedetomidine group compared post operatively. This confirms that 
dexmedetomidine known to cause fall in mean arterial pressure 
perioperatively. 
In our study, majority of the meperidine group patients had mean 
temperature ranging from 36.12 C and 35.90⁰C between baseline and 110 
minutes intraoperatively. Similarly majority of the dexmedetomidine 
group patients had mean temperature ranging from 35.89⁰C and 36.09⁰C 
between baseline and 110 minutes intraoperatively.  Usta et al in his 
study showed the mean temperature for saline group ranges from 36.8 to 
36.1⁰C and in dexmedetomidine group between 36.9 to 36.0⁰C. The 
association between the intervention groups and mean temperature is not 
statistically significant both in our study and Usta et al study. 
In our study, out of 80 patients 3 patients in dexmedetomidine 
group and 4 patients in meperidine group developed shivering with 
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lowest time of onset of shivering were 25 min in dexmedetomidine group 
and 20 min in meperidine group. Both dexmedetomidine and meperidine 
group patients had shivering grade ranging from 2 to 3 between baseline and 
65 minutes intraoperatively, which was not statistically significant. Those 
patients who developed shivering in both the groups were given 
dexmedetomidine as a rescue drug with dose of 0.3µg/kg body weight and 
shivering completely resolved in all the patients within 5 to 10 minutes 
except one in meperidine group. Fern and Misiran in their study 
demonstrated that all the three drugs dexmedetomidine, pethidine and 
tramadol were effective in treating post-neuraxial anaesthesia shivering. 
dexmedetomidine appears to be more effective than pethidine and 
tramadol (100% vs. 85% vs. 55%, respectively). However, the only 
significant difference statistically was demonstrated only between 
dexmedetomidine and tramadol and not between other drugs in reducing 
post-neuraxial anaesthesia shivering.  
In our study, sedation scores at intraoperative 20th to 100th min in 
dexmedetomidine group were significantly higher than the baseline 
values and values in meperidine group which was statistically significant. 
Most of the patients in dexmedetomidine group achieved the sedation 
score of 3 and in meperidine group achieved the score of 2.  Fern and 
Misiran in their study showed significant difference in sedation score 
among dexmedetomidine, meperidine and tramadol group respectively. In 
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the study by Bozgeyik et al, showed average sedation score of 3 in 
dexmedetomidine group which was statistically significant when 
compared to average score 2 in tramadol group intraoperatively. This 
sedation score in dexmedetomidine group might have removed anxiety in 
patients. 
In our study respiratory rate, oxygen saturation and side effect 
profile were not statistically significant. This observation was 
confirmed by similar findings in the study by Asif iqbal et al 
stating no significant difference in these variables between the study 
drugs. Asif iqbal et al in their study compared granisetron with 
meperidine. 
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CONCLUSION 
 
1. In our study, both the dexmedetomidine and meperidine were 
effective in the prevention of post spinal shivering. 
 
2.  Dexmedetomidine  had  better  sedation  profile without any 
respiratory depression and had less incidence of nausea and 
vomiting  when compared  to  pethidine. So,  it  can  be used as a 
better alternate for shivering  prophylaxis  in patients undergoing 
surgeries under regional anaesthesia . 
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LIMITATIONS 
 
1. Further studies are needed to evaluate the efficacy of 
dexmedetomidine in shivering control using different doses of 
dexmedetomidine. 
2. Haemodynamic  effects  of  dexmedetomidine are  to be studied in 
surgeries with longer duration  where the chance of developing 
hypothermia is more. 
3.  We could not measure the core body temperature. For 
measurement of core body temperature, the probe needs to be put 
in the oesophagus or near the tympanic membrane. Both these are 
uncomfortable and unacceptable who has been given spinal 
anaesthesia. Rectal temperature monitoring was a possibility but 
was not tried. 
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                                      ABBREVIATIONS 
 
1. I.V    -   intravenous 
2. I.M    -   intramuscular 
3. S.C    -   subcutaneous 
4. BPM -   beats per minute 
5. RR    -    respiratory rate 
6. MAP -    mean arterial pressure 
7. SAB -     Subarachnoid  block 
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PARTICIPANT INFORMATION SHEET 
We are conducting a study on the ““A Comparative study between 
Dexmedetomidine and meperidine in the prevention of  
intraoperative  shivering  in patients  undergoing  elective lower 
abdominal  surgeries under spinal anaesthesia” at the Department of 
Anaesthesiology, Govt. Kilpauk Medical College and Govt. Royapettah 
Hospital, Chennai. The aim of this study was to compare  the 
effectiveness  of  Dexmedetomidine  and meperidine  in the prevention 
of  intraoperative shivering  in patients  undergoing   lower  abdominal  
surgeries under spinal anaesthesia during the period March 2015 to July 
2015. 
 
 The privacy of the patients in the research will be maintained 
throughout the study. In the event of any publication or presentation 
resulting from the research, no personally identifiable information will 
be shared. 
 
 Taking part in this study is voluntary. You are free to decide whether 
to participate in this study or to withdraw at any time. Your decision 
will not result in any loss of benefits to which you are otherwise 
entitled. 
 
  The results of the study may be intimated to you at the end of the 
study period or during the study if anything is found abnormal which 
may aid in the management or treatment. 
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PATIENT CONSENT FORM 
Study title: “COMPARATIVE STUDY BETWEEN 
DEXMEDETOMIDINE AND MEPERIDINE IN THE PREVENTION OF 
INTRAOPERATIVE SHIVERING IN PATIENTS UNDERGOING LOWER 
ABDOMINAL SURGERIES UNDER SPINAL ANESTHESIA  
Paticipant name:                                  Age:                                       Sex:                        
I.P. No:        
I confirm that I have understood the purpose of the procedure for the above 
study. I have the opportunity to ask the question and all my questions and doubts have 
been answered to my satisfaction.   
I have been explained about the pitfall of the procedure. I have been explained 
about the safety, advantage and disadvantage of the technique.   
I understand that my participation in the study is voluntary and that I am free to 
withdraw at anytime without giving any reason.   
I understand that investigator, regulatory authorities and the ethical committee 
will not need my permission to look at my health records both in respect to the current 
study and any further research that may be conducted in relation to it, ven if I 
withdraw from the study. I understand that my identity will not be revealed in any 
information released to the third parties or published, unless as required under the 
law. I agree not to restrict the use of any data or results that arise from the study.   
Time:                                                      Signature/thumb impression of the participant:  
Date:                                                                                      Name of the Participant:  
Place:    
Signature of the investigator:  
Name of the investigator: 
 
 
 
 
 
PROFORMA 
“COMPARATIVE STUDY BETWEEN DEXMEDETOMIDINE AND 
MEPERIDINE IN THE PREVENTION OF INTRAOPERATIVE SHIVERING 
IN PATIENTS UNDERGOING LOWER ABDOMINAL SURGERIES UNDER 
SPINAL ANESTHESIA” 
Name :  
Age/Gender : 
IP. Number: 
Height:                          Weight: 
Date of surgery: 
ASA Physical status: 
Co morbidity : 
Drug history: 
Group (Tick any one) 
  Group-D: 0.5% Bupivacaine 3.5ml intrathecal+ 0.5mcg per kg 
dexmedetomidine  iv infusion in 100ml NS 
  Group-M: 0.5% Bupivacaine 3.5ml intrathecal + 0.5mg per kg meperidine iv 
bolus  in 100 ml NS 
Duration of surgery :              
  Medications :  
Inj. Atropine -0.6mg i.v  if PR< 50/min. 
Inj. Ephedrine 6 mg bolus if MAP falls below 20% of the baseline. 
Oxygen supplementation  
Inj. Ondansetron 8mg I.V if the patient develops nausea and vomiting. 
 
 
 
 
 
OBSERVATION 
 
TIME SpO2 
 
R R 
 
MAP Heart rate 
Shivering 
scale 
 
Temperature 
 
5 Min. after SAB¶       
10 Min. after SAB. ¶       
15 Min. after SAB. ¶       
20 Min. after SAB¶.       
25 Min. after SAB. ¶       
30 Min. after SAB. ¶       
35 Min. after SAB. ¶       
40 Min.  after SAB. ¶       
45 Min. after SAB¶       
50 Min. after SAB¶.       
55 Min.  after SAB. ¶       
60 Min. after SAB¶.       
65 Min. after SAB. ¶       
70 Min. after SAB. ¶       
75 Min. after SAB. ¶       
80 Min. after SAB. ¶       
85 Min. after SAB. ¶       
90 Min. after SAB. ¶       
 
  Till the end of the surgery 
 
 
 
 
 
 
 
Motor blockade (Bromage scale)*:  
Time 5 min 10 min 15 min 20 min 
Motor level     
*By Bromage scale every 5 minutes till it reaches the grade 4 
 
Sedation score:(Ramsay Sedation Scale (RSS)*: 
Time Sedation level 
Baseline  
10 min. after SAB¶  
20 min. after SAB¶  
30 min. after SAB¶  
40 min. after SAB¶  
50 min. after SAB¶  
60min. after SAB¶  
70 min. after SAB¶  
80 min. after SAB¶  
90 min. after SAB¶  
100 min. after SAB¶  
110 min . after SAB¶  
¶ SAB-subarachnoid block 
Any other complications seen: 
 
  
 
 
 
 
MASTER CHART 
MEPERIDINE[PETHIDINE] 
Sl. 
No. Name Age Sex Weight ASA 
Height         
in cms Ip No Surgery 
Heart rate 
Baseline 5 min 10min  15 min 20 min 25 min 30 min 35min 40min 45 min 50 min 
1 Selvaraj   35 M 65 1 168 2952    Rt Inguinal hernioplasty 82 70 74 78 86 82 77 80 86 87 84 
2 Sekar 32 M 58 1 164 2853     Lt Inguinal hernioplasty 76 74 81 84 84 83 86 75 77 73 67 
3 Raja 40 M 45 1 170 2581 Appendicectomy 86 89 82 102 102 94 96 90 94 78 72 
4 Vasanthi 43 F 54 2 158 2937 Onlay meshplasty 78 82 84 80 75 70 65 65 63 69 60 
5 kalidas 48 F 55 1 169    2790             B/L hernioplasty 84 86 82 84 83 84 68 78 76 80 74 
6 Mohd.iqbal 27 M 76 1 170 2342 L varicocelectomy 90 98 96 100 104 92 90 88 86 84 84 
7 Dhanasekar 52 M 63 2 166 3093 B/L eversion of sac 76 82 88 86 78 74 72 70 70 72 70 
8 Arivukarasu 28 M 52 1 168 3349 Appendicectomy 96 90 88 90 86 84 88 90 92 92 90 
9 Prakash 24 M 70 1 164 3358 Appendicectomy 88 85 89 82 80 81 84 80 78 81 78 
10 Muthu 44 M 72 2 160 3509 Rt Inguinal hernioplasty 86 82 64 58 68 68 76 74 82 70 72 
11 Esther 48 F 55 1 156 1468 TAH with BSO 90 96 98 97 92 88 84 86 80 82 80 
12 Mariyammal 51 F 45 1 154 1620 TAH with BSO 86 80 88 84 92 92 94 90 88 78 77 
13 Kosala 44 F 48 1 155 1428 Vaginal hysterectomy 78 80 82 75 74 72 70 68 69 70 71 
14 Unnamalai 56 F 56 2 158 1642 Vaginal hysterectomy 93 94 97 88 89 85 80 81 80 82 82 
15 Pattammal 56 F 49 1 152 1623 VH with PFR 70 64 66 64 68 68 60 67 69 70 68 
16 kumar 27 M 68 1 170 8626 Lt.Varicoelectomy 86 98 96 80 68 70 71 72 74 66 68 
17 kanchana 48 F 56 1 156 1518 TAH 74 72 70 68 67 66 69 67 68 70 67 
18 Rajeswari 34 F 50 1 160 1573 Ovarian cystectomy 90 84 85 94 103 106 96 92 90 86 87 
19 Velmurugan 28 M 68 1 168 3466              Haemorroidectoy 92 91 84 81 88 86 84 80 81 72 74 
20 S anthi 30 F 54 1 152 1480 Staging laprotomy &proceed 85 80 70 98 94 70 73 66 69 68 63 
21 RanjIth 38 M 74 1 166 3773 Appendicectomy 78 76 75 70 68 66 62 58 59 62 61 
22 Anbukarasi 39 F 56 1 169 1693 TAH 92 88 93 94 96 97 98 82 80 83 80 
23 Karmegam 45 M 66 1 172 3423 B/L eversion of sac 83 96 95 94 92 80 82 78 75 74 79 
24 Suresh 34 M 68 2 169 8499 vesicolithotripsy 93 92 94 104 106 103 91 90 82 83 80 
25 Balachander 36 M 75 2 166 8919 vesicolithotripsy 88 82 84 80 78 73 77 73 78 75 72 
26 mariyaal 47 M 52 1 152 1735 TAH with BSO 76 78 86 82 90 80 79 78 74 76 78 
27 Banupriya 39 F 61 1 160 1780 Staging laprotomy  88 66 64 72 71 70 68 70 72 73 71 
28 Senthilkumar 37 M 65 1 169 2772 L Hernioplasty 89 95 98 93 90 88 86 85 88 82 80 
29 rathinam 48 F 53 1 157 1984 Vaginal hysterctomy 82 86 85 80 84 80 79 80 82 76 81 
30 Anjalai 52 F 52 2 154 1953 TAH with BSO 85 98 97 94 95 90 88 86 82 86 80 
31 Nagaraj 45 M 71 2 168 2911 R Hernioplasty with Hydrocele 78 82 83 80 81 82 80 75 77 74 72 
32 Devi 28 F 48 1 160 1969 Ovarian cystectomy 82 84 86 85 87 89 79 79 73 74 75 
33 Venkatesan 46 M 68 1 176 2968 B/L Hernioplasty 71 79 82 76 72 74 73 70 72 76 68 
34 Jeyavel 19 M 72 1 168 2746 L inguinal hernioplasty 90 98 102 100 96 93 86 83 80 81 80 
35 Sathyabama 26 F 53 1 158 1908 Marsupialization R Ovary 76 79 80 74 71 70 58 59 62 64 62 
36 Marie 43 F 71 2 160 1986 Vaginal Hysterectomy 92 92 99 98 100 106 95 88 84 86 83 
37 Prabahakar 18 M 53 1 167 2989 Appendicectomy 83 94 96 95 93 90 85 86 74 78 77 
38 Marimuthu 28 M 66 1 169 3109 Appendicectomy 87 93 94 86 84 86 88 82 87 80 77 
39 KalaiSelvi 18 F 58 1 156 3124 Appendicectomy 94 83 86 89 89 91 79 80 82 83 80 
40 murugesan 50 M 64 1 169 3069 B/L eversion of sac 78 80 82 75 74 72 70 68 69 70 71 
 
 
 
 
HEART RATE 
 55 min 60min  65 min 70 min 75 min 80 min 85min 90min 95 min 100 min 110 min 
1 77 100 97 88 89 85 80 81 80 82 82 
2 82 88 90 92 80 78 70 74 69 70 68 
3 86 98 102 86 68 70 71 72 74 66 68 
4 74 72 80 76 67 66 69 67 68 70 67 
5 90 88 96 88 83 84 80 82 80 78 77 
6 86 88 94 92 90 80 79 78 74 76 78 
7 78 76 80 82 71 72 70 70 72 73 71 
8 90 95 106 97 90 88 86 85 88 82 80 
9 82 86 91 89 84 80 79 80 82 76 81 
10 85 98 97 94 95 90 88 86 82 86 80 
11 78 82 90 88 81 82 80 75 77 74 72 
12 82 84 88 88 87 89 79 79 73 74 75 
13 78 82 89 86 81 82 80 75 77 74 72 
14 82 84 92 87 87 89 79 79 73 74 75 
15 71 79 88 82 72 74 73 70 72 76 68 
16 71 79 88 82 72 74 73 70 72 76 68 
17 76 79 79 78 71 70 58 59 62 64 62 
18 92 92 98 100 100 106 95 88 84 86 83 
19 81 100 78 104 98 88 86 84 72 70 68 
20 90 96 104 100 92 88 84 86 80 82 80 
21 86 100 106 104 102 92 94 90 88 78 77 
22 78 80 88 79 74 72 70 68 69 70 71 
23 81 94 104 92 89 85 80 81 80 82 82 
24 82 84 90 88 80 78 70 74 69 70 68 
25 86 98 99 96 78 70 71 72 74 66 68 
26 76 82 94 86 78 74 72 70 70 72 70 
27 92 106 108 93 96 94 91 90 91 92 90 
28 83 85 94 82 80 81 84 80 78 81 78 
29 84 100 104 100 98 88 86 84 72 70 68 
30 90 96 108 104 92 88 84 86 80 82 80 
31 86 100 106 104 102 92 94 90 88 78 77 
32 78 80 86 78 74 72 70 68 69 70 71 
33 79 94 100 92 89 85 80 81 80 82 82 
34 78 76 80 72 68 66 62 58 59 62 61 
35 92 88 97 94 96 97 98 82 80 83 80 
36 83 96 100 94 92 80 82 78 75 74 79 
37 88 92 94 84 86 83 81 80 82 83 80 
38 88 82 84 80 78 73 77 73 78 75 72 
39 86 88 86 87 90 80 79 78 74 76 78 
40 78 76 80 82 71 72 70 70 72 73 71 
                                                                                                                                 
 
 
 
 
DEXMEDETOMIDINE 
Sl. 
No. Name Ag  e Sex Weight ASA Height in cms 
Ip 
No Surgery 
Heart rate 
Baseline 5 min 10 min 15min 20 min 25 min   30 min 35min 40 min 45 min 50 min 
41 Sakthivel 36 M 70 1 170 3313 appendicectomy 77 100 97 88 89 85 80 81 80 82 82 
42 Thangavel 40 M 59 1 158 3379 L Hernioplasty 82 88 90 92 80 78 70 74 69 70 68 
43 Malar 40 F 60 2 158 3591 Myomecctomy 86 98 102 86 68 70 71 72 74 66 68 
44 Rani 30 F 50 2 162 3564 Ward Mayo's 74 72 80 76 67 66 69 67 68 70 67 
45 Jesuraj 30 M 70 1 166 3557 Rt.Hernioplasty 90 88 96 88 83 84 80 82 80 78 77 
46 Sivanantham 55 M 52 1 168 2954 B/L Hydrocoele 86 88 94 92 90 80 79 78 74 76 78 
47 Iyappan 28 M 54 1 170 3588 R Hernioplasty 78 76 80 82 71 72 70 70 72 73 71 
48 meghala 30 F 60 1 160 1985 Myomectomy 90 95 106 97 90 88 86 85 88 82 80 
49 Ramya 25 F 48 1 156 3683 Appendicectomy 82 86 91 46 48 98 79 80 82 76 81 
50 Selvam 28 M 65 1 164 3505 L Hernioplasty 85 98 97 94 95 90 88 86 82 86 80 
51 ganesan 44 M 74 1 155 3267 Rt.Hernioplasty 78 82 90 88 81 82 80 75 77 74 72 
52 Krishnaveni 48 F 80 1 158 1955 TAH with BSO 82 84 88 88 87 89 79 79 73 74 75 
53 Pitchammal 58 F 71 1 152 1980 VH with PFR 78 82 89 86 81 82 80 75 77 74 72 
54 Manimaran 22 M 62 1 172 3766 Appendicectomy 82 84 92 87 87 89 79 79 73 74 75 
55 Sathya 34 F 54 1 156 3644 Onlay meshplasty 71 79 88 82 72 74 73 70 72 76 68 
56 Sundar 29 M 77 1 160 8808 varicoelectomy 71 79 88 82 72 74 73 70 72 76 68 
57 Mahamudha 30 F 64 2 168 1846 Hysteroscopy Guided D&C 76 79 79 78 48 52 58 59 62 64 62 
58 Manish 28 M 66 1 168 8508 vesicolithotripsy 92 92 98 100 100 106 95 88 84 86 83 
59 Dinesh 20 M 82 2 167 8683 Urethral diverticulectomy 81 100 78 104 98 88 86 84 72 70 68 
60 Kannadasan 20 M 55 1 169 3871 R Hernioplasty 90 96 94 100 92 88 84 86 80 82 80 
61 Sivaprakasam 25 M 54 1 172 3885 L Hernioplasty 86 100 106 104 102 92 94 90 88 78 77 
62 Vasantha 27 F 69 1 159 1910 Rt.ovarian cystectomy 78 80 88 79 74 72 70 68 69 70 71 
63 Sabarirajan 29 M 77 1 166 8705 Vesicolithotripsy 81 94 104 92 89 85 80 81 80 82 82 
64 Thillairani 32 F 69 1 152 1875 Myomectomy 82 84 90 88 80 78 70 74 69 70 68 
65 Parthiban 18 M 80 1 160 3469 Stage II urethroplasty 86 98 99 96 78 70 71 72 74 66 68 
66 Jayakodi 56 F 53 2 159 1966 TAH with BSO 76 82 94 86 78 74 72 70 70 72 70 
67 Murthy 35 M 55 1 157 3267 L Hernioplasty 92 106 108 93 96 94 91 90 91 92 90 
68 Dinesh 38 M 55 2 169 3975 R Hernioplasty 83 85 94 82 80 81 84 80 78 81 78 
69 Sathya 46 F 60 1 168 1847 TAH 84 86 78 47 98 88 86 84 72 70 68 
70 Swaminathan 29 M 54 1 169 8969               Satge I Urethroplasty 90 96 98 104 92 88 84 86 80 82 80 
71 Shantha 29 F 45 1 160 1826 Myomectomy 86 100 106 104 102 92 94 90 88 78 77 
72 Venkatesan 30 M 62 1 168 8726 Ca Penis Incision Biopsy 78 80 86 78 74 72 70 68 69 70 71 
73 Sivagami 25 F 59 1 158 3797 Hernioplasty 79 94 100 92 89 85 80 81 80 82 82 
74 Dhanam 32 F 57 1 160 1961 Staging laprotomy 78 76 80 72 68 66 62 58 59 62 61 
75 Devagi 33 F 45 1 158 3715 Hemorrhoidectomy 92 88 97 94 96 97 98 82 80 83 80 
76 Shyama 38 F 54 1 155 3907 R Hernioplasty 83 96 100 94 92 80 82 78 75 74 79 
77 Gomathy 30 F 50 1 156 1943 Onlay meshplasty 88 92 94 84 86 83 81 80 82 83 80 
78 Kavitha 37 F 67 1 160 3477 Mesh plasty 88 82 84 80 78 73 77 73 78 75 72 
79 Jayaraman 39 M 54 1 166 8941 Urethral diverticulectomy 86 88 86 87 90 80 79 78 74 76 78 
80 Bhuvaneswari 29 F 58 2 155 3467 Appendicectomy 78 76 80 82 71 72 70 70 72 73 71 
                                                                                                           
 
 
 
 
HEART RATE 
SL NO 55 min 60min  65 min 70 min 75 min 80 min 85min 90min 95 min 100 min 110 min 
41 70 74 78 86 82 77 80 86 87 84 77 
42 74 81 84 84 83 86 75 77 73 67 86 
43 89 82 102 102 94 96 90 94 78 72 96 
44 82 84 80 75 70 65 65 63 69 60 65 
45 86 82 84 83 84 68 78 76 80 74 68 
46 98 96 100 104 92 90 88 86 84 84 90 
47 82 88 86 78 74 72 70 70 72 70 72 
48 90 88 90 86 84 88 90 92 92 90 88 
49 85 89 82 80 81 84 80 78 81 78 84 
50 82 52 58 68 68 76 74 82 70             72 76 
51 96 98 97 92 88 84 86 80 82 80 84 
52 80 88 84 92 92 94 90 88 78 77 94 
53 80 82 75 74 72 70 68 69 70 71 70 
54 94 97 88 89 85 80 81 80 82 82 80 
55 64 66 64 68 68 60 67 69 70 68 60 
56 98 96 80 68 70 71 72 74 66 68 71 
57 72 70 68 67 66 69 67 68 70 67 69 
58 84 85 94 103 106 96 92 90 86 87 96 
59 91 84 81 88 86 84 80 81 72 74 84 
60 80 70 98 94 70 73 66 69 68 63 73 
61 76 75 70 68 66 62 58 59 62 61 62 
62 88 93 94 96 97 98 82 80 83 80 98 
63 96 95 94 92 80 82 78 75 74 79 82 
64 92 94               104 106 103 91 90 82 83 80 91 
65 82 84 80 78 73 77 73 78 75 72 77 
66 78 86 82 90 80 79 78 74 76 78 79 
67 66 64 72 71 70 68 70 72 73 71 68 
68 95 98 93 90 88 86 85 88 82 80 86 
69 86 85 80 84 80 79 80 82 76 81 79 
70 98 97 94 95 90 88 86 82 86 80 88 
71 82 83 80 81 82 80 75 77 74 72 80 
72 84 86 85 87 89 79 79 73 74 75 79 
73 79 82 76 72 74 73 70 72 76 68 73 
74 98 102 100 96 93 86 83 80 81 80 86 
75 79 80 74 71 70 58 59 62 64 62 58 
76 92 99 98 100 106 95 88 84 86 83 95 
77 94 96 95 93 90 85 86 74 78 77 85 
78 93 94 86 84 86 88 82 87 80 77 88 
79 83 86 89 89 91 79 80 82 83 80 79 
80 80 82 75 74 72 70 68 69 70 71 70 
 
 
 
 
 
 
 
MEPERIDINE 
Sl. 
No. Name 
MAP 
Baseline 5 min 10min 15 min 20min 25 min 30 min 35min 40min 45 min 50 min 55 min 60 min 65 min 70 min 75 min 80 min 85 min 90 min 95 min 100min 110 min 
1 Selvaraj 72 70 68 66 66 68 70 72 80 82 84 72 70 88 66 66 68 70 72 80 82 72 
2 Sekar 98 72 68 66 66 64 62 62 67 70 71 68 72 68 66 66 64 62 62 67 70 68 
3 Raja 84 82 80 82 82 80 76 76 80 84 89 84 82 80 82 82 80 76 76 80 84 84 
4 Vasanthi 75 75 77 78 74 71 70 96 86 88 87 75 75 77 78 74 71 70 96 86 88 75 
5 Kalidas 80 80 64 60 76 74 76 78 80 76 72 80 80 74 76 70 74 76 78 80 76 80 
6 Mohd.iqbal 80 82 84 80 82 82 80 82 84 82 79 80 82 84 80 82 82 80 82 84 82 80 
7 Dhansekar 78 74 60 56 78 80 74 76 77 77 79 78 74 70 76 78 80 74 76 77 77 78 
8 Arivukarasu 80 78 76 74 78 82 76 74 76 80 86 80 78 76 74 78 82 76 74 76 80 80 
9 Prakash 78 74 70 72 68 70 72 70 76 71 70 78 74 70 72 68 70 72 70 76 71 76 
10 Muthu 70 68 66 68 64 68 64 70 69 70 70 70 68 66 68 64 68 64 70 69 70 70 
11 Esther 78 70 56 72 68 68 62 68 67 69 70 68 70 56 72 68 68 62 68 67 69 68 
12 Mariyammal 76 74 72 70 68 74 72 76 74 77 80 76 74 72 70 68 74 72 76 74 77 76 
13 Kosala 72 68 64 64 62 82 68 70 77 72 79 72 68 66 70 72 70 68 70 77 72 72 
14 Unnamalai 72 74 80 73 72 70 72 70 71 70 77 72 74 80 73 72 70 72 70 71 70 72 
15 Pattammal 78 79 70 78 79 78 80 74 78 75 77 78 79 70 78 79 78 80 74 78 75 78 
16 kumar 78 70 70 72 70 73 70 70 76 72 75 68 70 70 72 70 73 70 70 76 72 68 
17 kanchana 73 68 72 68 65 82 63 64 65 66 66 68 68 72 68 65 82 63 64 65 66 68 
18 Rajeswari 84 67 67 62 68 67 69 67 65 69 70 54 67 67 62 68 67 69 67 65 69 54 
19 Velmurugan 88 88 72 70 73 70 78 76 74 77 71 88 88 72 70 73 70 78 76 74 77 80 
20 S anthi 78 72 70 70 70 77 72 70 73 68 74 78 72 70 70 70 77 72 70 73 68 78 
21 RanjIth 80 82 80 78 76 78 78 78 79 84 80 80 82 80 78 76 78 78 78 79 84 80 
22 Anbukarasi 70 72 77 72 72 70 72 72 77 74 76 70 72 77 72 72 70 72 72 77 74 70 
23 Karmegam 78 84 80 78 76 80 78 70 71 75 72 78 84 80 78 76 80 78 70 71 75 78 
24 Suresh 70 68 72 66 66 66 64 64 68 67 71 70 68 72 66 66 66 64 64 68 67 70 
25 Balachander 80 70 70 72 68 70 70 70 71 76 80 80 70 70 72 68 70 70 70 71 76 80 
26 mariyaal 70 82 80 84 80 82 80 81 84 82 89 70 82 80 84 80 82 80 81 84 82 70 
27 Banupriya 78 80 74 74 74 76 76 74 71 78 74 78 80 74 74 74 76 76 74 71 78 78 
28 Senthilkumar 84 67 67 62 68 67 69 67 68 70 74 74 67 67 62 68 67 69 67 68 70 74 
29 rathinam 78 76 76 74 74 76 74 70 72 69 79 78 76 76 74 74 76 74 70 72 69 78 
30 Anjalai 82 78 80 73 76 78 76 70 82 84 86 82 78 80 73 76 78 76 70 82 84 82 
31 Nagaraj 94 70 66 66 64 62 66 64 70 74 81 68 70 66 66 64 62 66 64 70 74 68 
32 Devi 80 78 72 72 72 76 74 74 76 74 79 80 78 72 72 72 76 74 74 76 74 80 
33 Venkatesan 82 68 56 56 76 76 74 64 68 67 69 62 68 72 66 66 66 64 64 68 67 62 
34 Jeyavel 84 70 78 76 80 78 78 70 72 71 79 84 70 78 76 80 78 78 70 72 71 84 
35 Sathyabama 70 72 70 68 64 66 64 64 64 69 72 70 72 70 68 64 66 64 64 64 69 70 
36 Marie 80 78 76 76 76 74 74 74 78 78 76 80 78 76 76 76 74 74 74 78 78 80 
37 Prabahakar 78 70 66 66 64 62 66 64 69 72 80 68 70 66 66 64 62 66 64 69 72 68 
38 Marimuthu 84 70 78 76 80 78 78 70 74 76 81 84 70 78 76 80 78 78 70 74 76 74 
39 KalaiSelvi 70 72 70 68 64 66 64 64 64 69 72 70 72 70 68 64 66 64 64 64 69 70 
40 murugesan 72 68 66 70 72 70 68 70 77 72 79 72 68 66 70 72 70 68 70 77 72 72 
 
 
 
 
DEXMEDETOMIDINE 
Sl. 
No. Name 
MAP 
                                                        
Baseline 5 min 10min 15 min 20min 25 min 30 min 35min 40min 45 min 50 min 55 min 60 min 65 min 70 min 75 min 80 min 85 min 90 min 95 min 100min 110 min 
41 Sakthivel 82 74 80 73 72 70 72 70 71 70 77 70 74 82 73 72 70 72 70 71 70 74 
42 Thangavel 96 79 70 78 79 78 80 74 78 75 77 78 79 70 78 79 78 80 74 78 75 77 
43 Malar 88 70 70 72 70 73 70 70 76 72 75 68 70 70 72 70 73 70 70 76 72 75 
44 Rani 88 68 72 68 65 82 63 64 65 68 76 78 78 72 73 75 82 73 74 75 76 76 
45 Jesuraj 74 67 67 62 68 77 79 67 75 69 70 74 67 67 62 68 67 69 67 65 69 70 
46 Sivanantham 88 88 72 70 73 70 78 76 74 77 71 88 88 72 70 73 70 78 76 74 77 71 
47 Iyappan 90 72 70 70 70 77 72 70 73 68 74 78 72 70 70 70 77 72 70 73 68 74 
48 meghala 78 80 74 74 74 76 76 74 71 78 74 78 80 74 74 74 76 76 74 71 78 72 
49 Ramya 88 72 70 58 58 78 79 67 68 70 74 73 67 67 62 68 67 69 67 68 70 74 
50 Selvam 90 76 76 74 74 76 74 70 72 69 79 78 76 76 74 74 76 74 70 72 69 79 
51 ganesan 82 78 80 73 76 78 76 70 82 84 86 82 78 80 73 76 78 76 70 82 84 76 
52 Krishnaveni 78 70 66 66 64 62 58 79 78 76 76 74 74 76 66 64 62 66 64 70 74 81 
53 Pitchammal 80 78 72 72 72 76 74 74 76 74 79 80 78 72 72 72 76 74 74 76 74 72 
54 Manimaran 82 68 72 66 66 66 64 64 68 67 69 62 68 72 66 66 66 64 64 68 67 69 
55 Sathya 84 70 78 76 80 78 78 70 72 71 79 84 70 78 76 80 78 78 70 72 71 79 
56 Sundar 84 70 78 76 80 78 78 70 72 71 79 84 70 78 76 80 78 78 70 72 71 74 
57 Mahamudha 108 74 70 76 78 80 74 76 77 77 79 78 74 70 76 78 80 74 76 77 77 79 
58 Manish 85 78 76 74 78 82 76 74 76 80 86 80 78 76 74 78 82 76 74 76 80 70 
59 Dinesh 98 74 70 72 68 70 72 70 76 71 70 78 74 70 72 68 70 72 70 76 71 70 
60 Kannadasan 92 68 72 66 66 66 64 64 68 67 69 62 68 72 66 66 66 64 64 68 67 69 
61 Sivaprakasam 84 70 78 76 80 78 78 70 72 71 79 84 70 78 76 80 78 78 70 72 71 79 
62 Vasantha   106 72 70 68 64 66 64 64 64 69 72 70 72 70 78 74 76 74 77 84 79 72 
63 Sabarirajan 80 78 76 76 76 74 74 74 78 78 76 80 78 76 76 76 74 74 74 78 78 76 
64 Thillairani 78 70 66 66 64 62 66 64 69 72 80 68 70 66 66 64 62 66 64 69 72 80 
65 Parthiban 72 70 68 66 66 68 70 72 80 82 84 72 70 68 66 66 68 70 72 80 82 80 
66 Jayakodi 78 72 70 70 70 77 72 70 73 68 74 78 72 70 70 70 77 72 70 73 68 74 
67 Murthy 80 82 80 78 76 78 78 78 79 84 80 80 82 80 78 76 78 78 78 79 84 80 
68 Dinesh 90 72 77 72 72 70 72 72 77 74 76 70 72 77 72 72 70 72 72 77 74 76 
69 Sathya 78 84 80 78 76 80 78 70 71 75 72 78 84 80 78 76 80 78 70 71 75 72 
70 Swaminathan 80 68 72 66 66 66 64 64 68 67 71 70 68 72 66 66 76 74 73 78 77 71 
71 Shantha 80 70 70 72 68 70 70 70 71 76 80 80 70 70 72 68 70 70 70 71 76 72 
72 Venkatesan 70 82 80 84 80 82 80 81 84 82 89 70 82 80 84 80 82 80 81 84 82 80 
73 Sivagami 97 80 74 74 74 76 76 74 71 78 74 78 80 74 74 74 76 76 74 71 78 74 
74 Dhanam 88 70 66 66 64 62 66 64 69 72 80 68 70 66 66 64 62 66 64 69 72 80 
75 Devagi 72 70 68 66 66 68 70 72 80 82 84 72 70 68 66 66 68 70 72 80 82 84 
76 Shyama 98 72 68 66 66 64 62 62 67 70 71 68 72 68 66 66 64 62 62 67 70 71 
77 Gomathy 84 82 80 82 82 80 76 76 80 84 89 84 82 80 82 82 80 76 76 80 84 79 
78 Kavitha 75 75 77 78 74 71 70 96 86 88 87 75 75 77 78 74 71 70 96 86 88 77 
79 Jayaraman 84 70 78 76 80 78 78 70 74 76 81 84 70 78 76 80 78 78 70 74 76 81 
80 Bhuvaneswari 70 72 70 68 64 66 64 64 64 69 72 70 72 70 68 64 66 64 64 64 69 72 
                                                                                   
 
 
 
 
MEPERIDINE 
Sl. 
No. Name 
TEMPERATURE 
 
Baseline 5 min 10min 15 min 20min 25 min 30 min 35min 40min 45 min 50 min 55 min 60 min 65 min 70 min 75 min 80 min 85 min 90 min 95 min 100min 
1 Raguvaran 36.3 35.9 35.9 36 36 36.1 36 36 36 36 36 36.3 35.9 35.9 36 36 36.1 36 36 36 36 
2 Sekar 36 35.9 35.8 35.9 36 36 36.1 36.1 36.1 36 36 36 35.9 35.8 35.9 36 36 36.1 36.1 36.1 36 
3 Devadoss 36.8 35.7 35.9 35.9 35.9 35.9 35.9 35.9 35.9 35.9 35.9 35.8 35.7 35.9 35.9 35.9 35.9 35.9 35.9 35.9 35.9 
4 Raja 36.4 36.3 36.2 36.2 36.2 36.2 36.2 36.2 36.2 36.2 36.3 36.4 36.3 36.2 36.2 36.2 36.2 36.2 36.2 36.2 36.2 
5 Vijaya 36.2 35.8 35.9 36.1 36.1 36.2 36.2 36.1 36.1 36.2 36.2 36.2 35.8 35.9 36.1 36.1 36.2 36.2 36.1 36.1 36.2 
6 Sahul ahamed 36.3 35.9 35.9 36 36 36.1 36 36 36 36 36 36.3 35.9 35.9 36 36 36.1 36 36 36 36 
7 Chandrasekaran 36 35.9 35.8 35.9 36 36 36.1 36.1 36.1 36 36 36 35.9 35.8 35.9 36 36 36.1 36.1 36.1 36 
8 Arivazhagan 36.0 35.7 35.9 35.9 35.9 35.9 35.9 35.9 35.9 35.9 35.9 35.8 35.7 35.9 35.9 35.9 35.9 35.9 35.9 35.9 35.9 
9 Prakash 36.4 36.3 36.2 36.2 36.2 36.2 36.2 36.2 36.2 36.2 36.3 36.4 36.3 36.2 36.2 36.2 36.2 36.2 36.2 36.2 36.2 
10 Muthu 36.3 35.9 35.8 35.8 35.9 35.9 36 36 36 36 36 36.3 35.9 35.8 35.8 35.9 35.9 36 36 36 36 
11 Marimuthu 36.2 36.1 36.1 36.2 36.2 36.3 36.3 36.3 36.3 36.2 36.3 36.2 36.1 36.1 36.2 36.2 36.3 36.3 36.3 36.3 36.2 
12 Kaliaperumal 36.1 36 36 36 35.9 36.2 36.1 36.1 36.1 36.1 36 36.1 36 36 36 35.9 36.2 36.1 36.1 36.1 36.1 
13 Jayanthi 36.9 35.7 35.8 35.9 35.9 35.9 35.9 35.8 35.8 35.8 35.8 35.9 35.7 35.8 35.9 35.9 35.9 35.9 35.8 35.8 35.8 
14 Govindan 36 35.9 35.8 36 36 36 36 36 36 36 36 36 35.9 35.8 36 36 36 36 36 36 36 
15 Manikandan 36.1 35.9 35.8 35.8 35.9 35.9 35.9 35.9 35.9 36 36 36.1 35.9 35.8 35.8 35.9 35.9 35.9 35.9 35.9 36 
16 kumar 36.8 35.7 35.7 35.8 35.8 35.8 35.8 35.8 35.8 35.8 35.8 35.8 35.7 35.7 35.8 35.8 35.8 35.8 35.8 35.8 35.8 
17 kanchana 36.2 36 36 36.1 36.1 36.1 36.1 36.1 36.1 36.1 36.1 36.2 36 36 36.1 36.1 36.1 36.1 36.1 36.1 36.1 
18 Rajeswari 36.1 35.9 35.8 35.9 36 36 36.1 36.1 36.1 36 36 36.1 35.9 35.8 35.9 36 36 36.1 36.1 36.1 36 
19 Velmurugan 35.8 35.7 35.9 35.9 35.9 35.9 35.9 35.9 35.9 35.9 35.9 35.8 35.7 35.9 35.9 35.9 35.9 35.9 35.9 35.9 35.9 
20 Santhi 36.3 36.3 36.2 36.2 36.2 36.2 36.2 36.2 36.2 36.2 36.3 36.3 36.3 36.2 36.2 36.2 36.2 36.2 36.2 36.2 36.2 
21 RanjIth 36.4 35.9 35.8 35.8 35.9 35.9 36 36 36 36 36 36.4 35.9 35.8 35.8 35.9 35.9 36 36 36 36 
22 Anbukarasi 36.3 36.1 36.1 36.2 36.2 36.3 36.3 36.3 36.3 36.2 36.3 36.3 36.1 36.1 36.2 36.2 36.3 36.3 36.3 36.3 36.2 
23 Karmegam 36.1 36 36 36 35.9 36.2 36.1 36.1 36.1 36.1 36 36.1 36 36 36 35.9 36.2 36.1 36.1 36.1 36.1 
24 Suresh 36 35.9 35.8 36 36 36 36 36 36 36 36 36 35.9 35.8 36 36 36 36 36 36 36 
25 Balachander 36.1 35.9 35.8 35.8 35.9 35.9 35.9 35.9 35.9 36 36 36.1 35.9 35.8 35.8 35.9 35.9 35.9 35.9 35.9 36 
26 mariyaal 36.8 35.7 35.7 35.8 35.8 35.8 35.8 35.8 35.8 35.8 35.8 35.8 35.7 35.7 35.8 35.8 35.8 35.8 35.8 35.8 35.8 
27 Banupriya 36.2 36 36 36.1 36.1 36.1 36.1 36.1 36.1 36.1 36.1 36.2 36 36 36.1 36.1 36.1 36.1 36.1 36.1 36.1 
28 Senthilkumar 36.1 35.9 35.8 35.9 36 36 36.1 36.1 36.1 36 36 36.1 35.9 35.8 35.9 36 36 36.1 36.1 36.1 36 
29 rathinam 37.0 35.7 35.9 35.9 35.9 35.9 35.9 35.9 35.9 35.9 35.9 35.8 35.7 35.9 35.9 35.9 35.9 35.9 35.9 35.9 35.9 
30 Anjalai 36.1 35.9 35.8 35.8 35.9 35.9 35.9 35.9 35.9 36 36 36.1 35.9 35.8 35.8 35.9 35.9 35.9 35.9 35.9 36 
31 Nagaraj 36.8 35.7 35.7 35.8 35.8 35.8 35.8 35.8 35.8 35.8 35.8 35.8 35.7 35.7 35.8 35.8 35.8 35.8 35.8 35.8 35.8 
32 Devi 36.2 36 36 36.1 36.1 36.1 36.1 36.1 36.1 36.1 36.1 36.2 36 36 36.1 36.1 36.1 36.1 36.1 36.1 36.1 
33 Venkatesan 36.1 35.9 35.8 35.9 36 36 36.1 36.1 36.1 36 36 36.1 35.9 35.8 35.9 36 36 36.1 36.1 36.1 36 
34 Jeyavel 36.0 35.7 35.9 35.9 35.9 35.9 35.9 35.9 35.9 35.9 35.9 35.8 35.7 35.9 35.9 35.9 35.9 35.9 35.9 35.9 35.9 
35 Sathyabama 36.3 36.3 36.2 36.2 36.2 36.2 36.2 36.2 36.2 36.2 36.3 36.3 36.3 36.2 36.2 36.2 36.2 36.2 36.2 36.2 36.2 
36 Marie 36.1 35.9 35.8 35.9 36 36 36.1 36.1 36.1 36 36 36.1 35.9 35.8 35.9 36 36 36.1 36.1 36.1 36 
37 Prabahakar 36.8 35.7 35.7 35.8 35.8 35.8 35.8 35.8 35.8 35.8 35.8 35.8 35.7 35.7 35.8 35.8 35.8 35.8 35.8 35.8 35.8 
38 Marimuthu 36.3 35.9 35.8 35.8 35.9 35.9 36 36 36 36 36 36.3 35.9 35.8 35.8 35.9 35.9 36 36 36 36 
39 KalaiSelvi 36.2 36.1 36.1 36.2 36.2 36.3 36.3 36.3 36.3 36.2 36.3 36.2 36.1 36.1 36.2 36.2 36.3 36.3 36.3 36.3 36.2 
40 murugesan 36.1 35.9 35.8 35.9 36 36 36.1 36.1 36.1 36 36 36.1 35.9 35.8 35.9 36 36 36.1 36.1 36.1 36 
                                                                                    
 
 
 
 
DEXMEDETOMIDINE 
Sl. 
No. Name 
Temperature 
 
Baseline 5 min 10min 15 min 20min 25 min 30 min 35min 40min 45 min 50 min 55 min 60 min 65 min 70 min 75 min 80 min 85 min 90 min 95 min 100min 110 min 
41 Sakthivel 36.2 36 36 36.1 36.1 36.1 36.1 36.1 36.1 36.1 36.1 36.2 36 36 36.1 36.1 36.1 36.1 36.1 36.1 36.1 36.1 
42 Thangavel 36.1 35.9 35.8 35.9 36 36 36.1 36.1 36.1 36 36 36.1 35.9 35.8 35.9 36 36 36.1 36.1 36.1 36 36 
43 Malar 36.0 35.7 35.9 35.9 35.9 35.9 35.9 35.9 35.9 35.9 35.9 35.8 35.7 35.9 35.9 35.9 35.9 35.9 35.9 35.9 35.9 35.9 
44 Rani 36.3 36.3 36.2 36.2 36.2 36.2 36.2 36.2 36.2 36.2 36.3 36.3 36.3 36.2 36.2 36.2 36.2 36.2 36.2 36.2 36.2 36.3 
45 Jesuraj 36.4 35.9 35.8 35.8 35.9 35.9 36 36 36 36 36 36.4 35.9 35.8 35.8 35.9 35.9 36 36 36 36 36 
46 Sivanantham 36.3 36.1 36.1 36.2 36.2 36.3 36.3 36.3 36.3 36.2 36.3 36.3 36.1 36.1 36.2 36.2 36.3 36.3 36.3 36.3 36.2 36.3 
47 Iyappan 36.5 36 36 36 35.9 36.2 36.1 36.1 36.1 36.1 36 36 36 36 36 35.9 36.2 36.1 36.1 36.1 36.1 36 
48 meghala 36.1 35.9 35.8 36 36 36 36 36 36 36 36 36.1 35.9 35.8 36 36 36 36 36 36 36 36 
49 Ramya 36.1 35.9 35.8 35.8 35.9 35.9 35.9 35.9 35.9 36 36 36.1 35.9 35.8 35.8 35.9 35.9 35.9 35.9 35.9 36 36 
50 Selvam 36.7 35.7 35.7 35.8 35.8 35.8 35.8 35.8 35.8 35.8 35.8 35.7 35.7 35.7 35.8 35.8 35.8 35.8 35.8 35.8 35.8 35.8 
51 ganesan 36.2 36 36 36.1 36.1 36.1 36.1 36.1 36.1 36.1 36.1 36.2 36 36 36.1 36.1 36.1 36.1 36.1 36.1 36.1 36.1 
52 Krishnaveni 36.2 35.9 35.8 35.9 36 36 36.1 36.1 36.1 36 36 36.2 35.9 35.8 35.9 36 36 36.1 36.1 36.1 36 36 
53 Pitchammal 36.4 35.7 35.9 35.9 35.9 35.9 35.9 35.9 35.9 35.9 35.9 35.8 35.7 35.9 35.9 35.9 35.9 35.9 35.9 35.9 35.9 35.9 
54 Manimaran 36.1 35.9 35.8 35.8 35.9 35.9 35.9 35.9 35.9 36 36 36.1 35.9 35.8 35.8 35.9 35.9 35.9 35.9 35.9 36 36 
55 Sathya 36.8 35.7 35.7 35.8 35.8 35.8 35.8 35.8 35.8 35.8 35.8 35.8 35.7 35.7 35.8 35.8 35.8 35.8 35.8 35.8 35.8 35.8 
56 Sundar 36.1 36 36 36 35.9 36.2 36.1 36.1 36.1 36.1 36 36.1 36 36 36 35.9 36.2 36.1 36.1 36.1 36.1 36 
57 Mahamudha 36.2 35.9 35.8 36 36 36 36 36 36 36 36 36.2 35.9 35.8 36 36 36 36 36 36 36 36 
58 Manish 36.1 35.9 35.8 35.8 35.9 35.9 35.9 35.9 35.9 36 36 36.1 35.9 35.8 35.8 35.9 35.9 35.9 35.9 35.9 36 36 
59 Dinesh 36.0 35.7 35.7 35.8 35.8 35.8 35.8 35.8 35.8 35.8 35.8 35.7 35.7 35.7 35.8 35.8 35.8 35.8 35.8 35.8 35.8 35.8 
60 Kannadasan 36.3 36 36 36.1 36.1 36.1 36.1 36.1 36.1 36.1 36.1 36.3 36 36 36.1 36.1 36.1 36.1 36.1 36.1 36.1 36.1 
61 Sivaprakasam 36.3 36 36 36.1 36.1 36.1 36.1 36.1 36.1 36.1 36.1 36.3 36 36 36.1 36.1 36.1 36.1 36.1 36.1 36.1 36.1 
62 Vasantha 36.7 35.7 35.9 35.9 35.9 35.9 35.9 35.9 35.9 35.9 35.9 35.7 35.7 35.9 35.9 35.9 35.9 35.9 35.9 35.9 35.9 35.9 
63 Sabarirajan 36.1 35.9 35.8 35.8 35.9 35.9 35.9 35.9 35.9 36 36 36.1 35.9 35.8 35.8 35.9 35.9 35.9 35.9 35.9 36 36 
64 Thillairani 36.7 35.7 35.7 35.8 35.8 35.8 35.8 35.8 35.8 35.8 35.8 35.7 35.7 35.7 35.8 35.8 35.8 35.8 35.8 35.8 35.8 35.8 
65 Parthiban 36.2 36 36 36.1 36.1 36.1 36.1 36.1 36.1 36.1 36.1 36.2 36 36 36.1 36.1 36.1 36.1 36.1 36.1 36.1 36.1 
66 Jayakodi 36.2 35.9 35.8 35.9 36 36 36.1 36.1 36.1 36 36 36.2 35.9 35.8 35.9 36 36 36.1 36.1 36.1 36 36 
67 Murthy 36.8 35.7 35.9 35.9 35.9 35.9 35.9 35.9 35.9 35.9 35.9 35.8 35.7 35.9 35.9 35.9 35.9 35.9 35.9 35.9 35.9 35.9 
68 Dinesh 36.3 36.3 36.2 36.2 36.2 36.2 36.2 36.2 36.2 36.2 36.3 36.3 36.3 36.2 36.2 36.2 36.2 36.2 36.2 36.2 36.2 36.3 
69 Sathya 36.1 35.9 35.8 35.9 36 36 36.1 36.1 36.1 36 36 36.1 35.9 35.8 35.9 36 36 36.1 36.1 36.1 36 36 
70 Swaminathan 36.2 35.8 35.9 36.1 36.1 36.2 36.2 36.1 36.1 36.2 36.2 36.2 35.8 35.9 36.1 36.1 36.2 36.2 36.1 36.1 36.2 36.2 
71 Shantha 36.3 35.9 35.9 36 36 36.1 36 36 36 36 36 36.3 35.9 35.9 36 36 36.1 36 36 36 36 36 
72 Venkatesan 36.2 35.9 35.8 35.9 36 36 36.1 36.1 36.1 36 36 36.2 35.9 35.8 35.9 36 36 36.1 36.1 36.1 36 36 
73 Sivagami 36.8 35.7 35.9 35.9 35.9 35.9 35.9 35.9 35.9 35.9 35.9 35.8 35.7 35.9 35.9 35.9 35.9 35.9 35.9 35.9 35.9 35.9 
74 Dhanam 36.4 36.3 36.2 36.2 36.2 36.2 36.2 36.2 36.2 36.2 36.3 36.4 36.3 36.2 36.2 36.2 36.2 36.2 36.2 36.2 36.2 36.3 
75 Devagi 36.3 35.9 35.8 35.8 35.9 35.9 36 36 36 36 36 36.3 35.9 35.8 35.8 35.9 35.9 36 36 36 36 36 
76 Shyama 36.2 36.1 36.1 36.2 36.2 36.3 36.3 36.3 36.3 36.2 36.3 36.2 36.1 36.1 36.2 36.2 36.3 36.3 36.3 36.3 36.2 36.3 
77 Gomathy 36.1 36 36 36 35.9 36.2 36.1 36.1 36.1 36.1 36 36.1 36 36 36 35.9 36.2 36.1 36.1 36.1 36.1 36 
78 Kavitha 36.9 35.7 35.8 35.9 35.9 35.9 35.9 35.8 35.8 35.8 35.8 35.9 35.7 35.8 35.9 35.9 35.9 35.9 35.8 35.8 35.8 35.8 
79 Jayaraman 36.1 35.9 35.8 36 36 36 36 36 36 36 36 36.1 35.9 35.8 36 36 36 36 36 36 36 36 
80 Bhuvaneswari 36.4 35.9 35.8 35.8 35.9 35.9 35.9 35.9 35.9 36 36 36 35.9 35.8 35.8 35.9 35.9 35.9 35.9 35.9 36 36 
 
 
 
 
 
 
MEPERIDINE                                                            
Sl. 
No. Name 
Shivering grade 
 
Baseline 5 min 10min 15 min 20min 25 min 30 min 35min 40min 45 min 50 min 55 min 60 min 65 min 70 min 75 min 80 min 85 min 90 min 95 min 100min 
1 Raguvaran 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
2 Sekar 0 0 0 2 3 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
3 Devadoss 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
4 Raja 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
5 Vijaya 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
6 Sahul ahamed 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
7 Chandrasekaran 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
8 Arivazhagan 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
9 Prakash 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
10 Muthu 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
11 Marimuthu 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
12 Kaliaperumal 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
13 Jayanthi 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
14 Govindan 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
15 Manikandan 0 0 0 0 0 0 0 0 3 3 2 2 2 0 0 0 0 0 0 0 0 
16 kumar 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
17 kanchana 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
18 Rajeswari 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
19 Velmurugan 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
20 Santhi 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
21 RanjIth 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
22 Anbukarasi 0 0 0 0 0 2 2 3 3 0 0 0 0 0 0 0 0 0 0 0 0 
23 Karmegam 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
24 Suresh 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
25 Balachander 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
26 mariyaal 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
27 Banupriya 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
28 Senthilkumar 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
29 rathinam 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
30 Anjalai 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
31 Nagaraj 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
32 Devi 0 0 0 0 0 0 3 3 2 2 2 0 0 0 0 0 0 0 0 0 0 
33 Venkatesan 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
34 Jeyavel 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
35 Sathyabama 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
36 Marie 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
37 Prabahakar 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
38 Marimuthu 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
39 KalaiSelvi 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
40 murugesan 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
 
 
 
 
 
DEXMEDETOMIDINE 
Sl. 
No. Name 
Shivering grade 
 
Baseline 5 min 10min 15 min 20min 25 min 30 min 35min 40min 45 min 50 min 55 min 60 min 65 min 70 min 75 min 80 min 85 min 90 min 95 min 100min 
41 Sakthivel 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
42 Thangavel 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
43 Malar 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
44 Rani 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
45 Jesuraj 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
46 Sivanantham 0 0 0 0 0 0 2 3 3 0 0 0 0 0 0 0 0 0 0 0 0 
47 Iyappan 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
48 meghala 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
49 Ramya 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
50 Selvam 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
51 ganesan 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
52 Krishnaveni 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
53 Pitchammal 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
54 Manimaran 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
55 Sathya 0 0 0 0 3 3 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
56 Sundar 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
57 Mahamudha 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
58 Manish 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
59 Dinesh 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
60 Kannadasan 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
61 Sivaprakasam 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
62 Vasantha 0 0 0 0 0 2 3 3 2 0 0 0 0 0 0 0 0 0 0 0 0 
63 Sabarirajan 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
64 Thillairani 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
65 Parthiban 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
66 Jayakodi 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
67 Murthy 0 0 0 0 o 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
68 Dinesh 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
69 Sathya 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
70 Swaminathan 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
71 Shantha 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
72 Venkatesan 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
73 Sivagami 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
74 Dhanam 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
75 Devagi 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
76 Shyama 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
77 Gomathy 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
78 Kavitha 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
79 Jayaraman 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
80 Bhuvaneswari 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
                                                               
 
 
 
 
MEPERIDINE 
Sl. 
No. Name- 
Sedation score                     Nausea/                                              Vomiting 
Pre- op 10min 20 min 30 min 40 min 50 min 60min 70 min 80 min 90 min 100 min 110 min  
1 Selvaraj 0 2 2 2 2 2 2 2 2 2 2 2  
2 Sekar 0 2 2 2 2 2 2 2 2 2 2 2 + 
3 Raja 0 2 2 2 2 2 2 2 2 2 2 2  
4 Vasanthi 0 2 2 2 2 2 2 2 2 2 2 2  
5 kalidas 0 2 2 2 2 2 2 2 2 2 2 2  
6 Mohd.iqbal 0 2 2 2 2 2 2 2 2 2 2 2 + 
7 Dhanasekar 0 2 2 2 2 2 2 2 2 2 2 2  
8 Arivukarasu 0 2 2 2 2 2 2 2 2 2 2 2  
9 Prakash 0 2 2 2 2 2 2 2 2 2 2 2  
10 Muthu 0 2 2 2 2 2 2 2 2 2 2 2 + 
11 Esther 0 2 2 2 2 2 2 2 2 2 2 2  
12 Mariyammal 0 2 2 2 2 2 2 2 2 2 2 2  
13 Kosala 0 2 2 2 2 2 2 2 2 2 2 2  
14 Unnamalai 0 2 2 2 2 2 2 2 2 2 2 2  
15 Pattammal 0 2 2 2 2 2 2 2 2 2 2 2  
16 Kumar 0 2 2 2 2 2 2 2 2 2 2 2  
17 Kanchana 0 2 2 2 2 2 2 2 2 2 2 2  
18 Rajeswari 0 2 2 2 2 2 2 2 2 2 2 2  
19 Velmurugan 0 2 2 2 2 2 2 2 2 2 2 2  
20 S anthi 0 2 2 2 2 2 2 2 2 2 2 2  
21 RanjIth 0 2 2 2 2 2 2 2 2 2 2 2 + 
22 Anbukarasi 0 2 2 2 2 2 2 2 2 2 2 2  
23 Karmegam 0 2 2 2 2 2 2 2 2 2 2 2  
24 Suresh 0 2 2 2 2 2 2 2 2 2 2 2  
25 Balachander 0 2 2 2 2 2 2 2 2 2 2 2  
26 mariyaal 0 2 2 2 2 2 2 2 2 2 2 2  
27 Banupriya 0 2 2 2 2 2 2 2 2 2 2 2  
28 Senthilkumar 0 2 2 2 2 2 2 2 2 2 2 2 + 
29 rathinam 0 2 2 2 2 2 2 2 2 2 2 2  
30 Anjalai 0 2 2 2 2 2 2 2 2 2 2 2  
31 Nagaraj 0 2 2 2 2 2 2 2 2 2 2 2  
32 Devi 0 2 2 2 2 2 2 2 2 2 2 2  
33 Venkatesan 0 2 2 2 2 2 2 2 2 2 2 2  
34 Jeyavel 0 2 2 2 2 2 2 2 2 2 2 2  
35 Sathyabama 0 2 2 2 2 2 2 2 2 2 2 2 + 
36 Marie 0 2 2 2 2 2 2 2 2 2 2 2  
37 Prabahakar 0 2 2 2 2 2 2 2 2 2 2 2  
38 Marimuthu 0 2 2 2 2 2 2 2 2 2 2 2  
39 KalaiSelvi 0 2 2 2 2 2 2 2 2 2 2 2  
40 murugesan 0 2 2 2 2 2 2 2 2 2 2 2  
 
 
 
 
DEXMEDETOMIDINE 
 
 
 
 
 
Name 
Sedation score 
 
 
Nausea/ 
Vomiting 
Pre- op 10min 20 min 30 min 40 min 50 min 60min 70 min 80 min 90 min 100min 110min  
41 Sakthivel 0 2 2 2 3 3 3 3 3 3 3 3  
42 Thangavel 0 2 3 3 3 3 3 3 3 3 3 3  
43 Malar 0 2 3 3 3 3 3 3 3 3 3 2  
44 Rani 0 2 3 3 3 3 3 3 3 3 3 2  
45 Jesuraj 0 2 3 3 3 3 3 3 3 3 3 3  
46 Sivanantham 0 2 3 3 3 3 3 3 3 3 3 2  
47 Iyappan 0 2 3 3 3 3 3 3 3 3 3 2  
48 meghala 0 2 3 3 3 3 3 3 3 3 3 2  
49 Ramya 0 2 3 3 3 3 3 3 3 3 3 2  
50 Selvam 0 2 3 3 3 3 3 2 2 3 3 2 + 
51 ganesan 0 2 3 3 3 3 3 3 3 3 3 2  
52 Krishnaveni 0 2 3 3 3 3 3 3 3 3 3 2  
53 Pitchammal 0 2 3 3 3 3 3 3 3 3 3 2  
54 Manimaran 0 2 3 3 3 3 3 3 3 3 3 2  
55 Sathya 0 2 3 3 3 3 3 3 3 3 3 3  
56 Sundar 0 2 3 3 3 3 3 3 3 3 3 2  
57 Mahamudha 0 2 3 3 3 3 3 3 3 3 3 2  
58 Manish 0 2 3 3 3 3 3 2 2 2 2 2  
59 Dinesh 0 2 3 3 3 3 3 3 3 3 3 2  
60 Kannadasan 0 2 3 3 3 3 3 3 3 3 3 2 + 
61 Sivaprakasam 0 2 3 3 3 3 3 3 3 3 3 2  
62 Vasantha 0 2 3 3 3 3 3 3 3 3 3 2  
63 Sabarirajan 0 2 3 3 3 3 3 3 3 3 3 3  
64 Thillairani 0 2 3 3 3 3 3 3 3 3 3 2  
65 Parthiban 0 2 3 3 3 3 3 3 3 3 3 2  
66 Jayakodi 0 2 3 3 3 3 3 3 3 3 3 2  
67 Murthy 0 2 3 3 3 3 3 3 3 3 3 3  
68 Dinesh 0 2 3 3 3 3 3 3 3 3 3 2  
69 Sathya 0 2 3 3 3 3 2 2 2 2 2 2  
70 Swaminathan 0 2 3 3 3 3 3 3 3 3 3 2  
71 Shantha 0 2 3 3 3 3 3 3 3 3 3 2  
72 Venkatesan 0 2 3 3 3 3 3 3 3 3 3 2  
73 Sivagami 0 2 3 3 3 3 3 3 3 3 3 2  
74 Dhanam 0 2 3 3 3 3 3 3 3 3 3 2  
75 Devagi 0 2 3 3 3 3 3 3 3 3 3 2  
76 Shyama 0 2 3 3 3 3 3 3 3 3 3 2  
77 Gomathy 0 2 3 3 3 3 3 3 3 3 3 2  
78 Kavitha 0 2 3 3 3 3 3 3 3 3 3 2  
79 Jayaraman 0 2 3 3 3 3 3 3 3 3 3 2  
80 Bhuvaneswari 0 2 3 3 3 3 3 3 3 3 3 2  
 
 
 
 
 
MEPERIDINE 
Sl. 
No. Name- 
 
RESPIRATORY RATE 
 
Pre- op 10min 20 min 30 min 40 min 50 min 60min 70 min 80 min 90 min 100 min 110 min 
1 Selvaraj 14 14 14 14 14 14 13 13 13 14 14 14 
2 Sekar 13 13 13 13 13 13 13 13 13 13 13 13 
3 Raja 12 12 12 12 12 12 12 12 12 12 12 12 
4 Vasanthi 13 13 13 13 13 11 10 10 12 13 13 13 
5 kalidas 14 14 14 14 14 14 14 14 14 14 14 14 
6 Mohd.iqbal 14 14 14 14 13 14 12 14 14 14 14 14 
7 Dhanasekar 14 14 14 14 11 14 14 14 14 14 14 14 
8 Arivukarasu 12 12 12 12 12 12 12 12 12 12 12 12 
9 Prakash 13 13 13 12 12 11 13 13 13 13 13 13 
10 Muthu 14 14 14 13 14 14 14 14 14 14 13 14 
11 Esther 12 12 12 12 12 12 12 12 12 12 12 12 
12 Mariyammal 13 13 13 13 13 13 13 13 13 13 13 13 
13 Kosala 14 14 14 14 13 13 13 14 14 14 13 14 
14 Unnamalai 12 12 12 12 12 12 12 12 12 12 12 12 
15 Pattammal 12 12 12 12 12 12 12 12 12 12 12 12 
16 Kumar 12 12 12 12 12 12 12 12 12 12 12 12 
17 Kanchana 12 12 12 12 12 12 12 12 12 12 12 12 
18 Rajeswari 12 12 12 12 12 12 12 12 12 12 12 12 
19 Velmurugan 12 12 12 12 12 12 12 12 12 12 12 12 
20 S anthi 14 14 13 13 10 12 13 14 13 14 14 14 
21 RanjIth 13 13 13 13 13 13 12 13 13 13 13 13 
22 Anbukarasi 13 13 13 13 13 12 13 13 13 13 13 13 
23 Karmegam 12 12 12 12 12 12 12 12 12 12 12 12 
24 Suresh 14 14 14 14 14 11 11 12 12 13 13 14 
25 Balachander 13 13 13 13 12 13 13 12 13 13 13 13 
26 mariyaal 12 12 12 12 12 12 12 12 12 12 12 12 
27 Banupriya 13 13 13 13 13 13 13 13 13 13 13 13 
28 Senthilkumar 14 14 14 12 10 10 11 10 12 12 14 14 
29 rathinam 12 12 12 12 12 12 12 12 12 12 12 12 
30 Anjalai 12 12 12 12 12 12 12 12 12 12 12 12 
31 Nagaraj 12 12 12 12 12 12 12 12 12 12 12 12 
32 Devi 12 12 12 12 12 12 12 12 12 12 12 12 
33 Venkatesan 13 13 13 13 13 13 13 13 13 13 13 13 
34 Jeyavel 12 12 12 12 12 12 12 12 12 12 12 12 
35 Sathyabama 12 12 12 12 12 12 12 12 12 12 12 12 
36 Marie 12 12 12 12 12 12 12 12 12 12 12 12 
37 Prabahakar 14 14 14 14 14 14 14 14 14 14 14 14 
38 Marimuthu 12 12 12 12 12 12 12 12 12 12 12 12 
39 KalaiSelvi 13 13 13 13 13 13 13 13 13 13 13 13 
40 murugesan 12 12 12 12 12 12 12 12 12 12 12 12 
 
 
 
 
DEXMEDETOMIDINE 
Sl. 
No. Name 
 
RESPIRATORY  RATE 
 
Pre- op 10min 20 min 30 min 40 min 50 min 60min 70 min 80 min 90 min 100 min 110 min 
41 Sakthivel 12 12 12 12 12 12 12 12 12 12 12 12 
42 Thangavel 12 12 12 12 12 12 12 12 12 12 12 12 
43 Malar 12 12 12 12 12 12 12 12 12 12 12 12 
44 Rani 14 14 14 13 14 14 14 13 14 14 14 14 
45 Jesuraj 12 12 12 12 12 12 12 12 12 12 12 12 
46 Sivanantham 12 12 12 12 12 12 12 12 12 12 12 12 
47 Iyappan 14 14 13 14 14 14 14 14 14 14 14 14 
48 meghala 12 12 12 12 12 12 12 12 12 12 12 12 
49 Ramya 12 12 12 12 12 12 12 12 12 12 12 12 
50 Selvam 13 13 13 13 14 13 13 14 13 13 13 13 
51 ganesan 12 12 12 12 12 12 12 12 12 12 12 12 
52 Krishnaveni 12 12 12 12 12 12 12 12 12 12 12 12 
53 Pitchammal 12 12 12 12 12 12 12 12 12 12 12 12 
54 Manimaran 12 12 12 12 12 12 12 12 12 12 12 12 
55 Sathya 12 12 12 12 12 12 12 12 12 12 12 12 
56 Sundar 13 12 13 13 13 13 13 13 13 13 13 13 
57 Mahamudha 12 12 12 12 12 12 12 12 12 12 12 12 
58 Manish 12 12 12 12 12 12 12 12 12 12 12 12 
59 Dinesh 12 12 12 12 12 12 12 12 12 12 12 12 
60 Kannadasan 14 12 12 12 12 12 12 12 12 12 12 12 
61 Sivaprakasam 13 12 12 12 12 12 12 12 12 12 12 12 
62 Vasantha 12 12 12 12 12 12 12 12 12 12 12 12 
63 Sabarirajan 12 12 12 12 12 12 12 12 12 12 12 12 
64 Thillairani 14 12 12 12 12 12 12 12 12 12 12 12 
65 Parthiban 13 12 12 12 12 12 12 12 12 12 12 12 
66 Jayakodi 12 12 12 12 12 12 12 12 12 12 12 12 
67 Murthy 13 12 12 12 12 12 12 12 12 12 12 12 
68 Dinesh 14 14 14 14 14 14 14 14 14 13 14 14 
69 Sathya 12 12 12 12 12 12 12 12 12 12 12 12 
70 Swaminathan 12 12 12 12 12 12 12 12 12 12 12 12 
71 Shantha 12 12 12 12 12 12 12 12 12 12 12 12 
72 Venkatesan 14 12 12 12 12 12 12 12 12 12 12 12 
73 Sivagami 14 12 12 12 12 12 12 12 12 12 12 12 
74 Dhanam 12 12 12 12 12 12 12 12 12 12 12 12 
75 Devagi 12 12 12 12 12 12 12 12 12 12 12 12 
76 Shyama 14 12 14 14 14 14 13 12 14 14 14 14 
77 Gomathy 12 12 12 12 12 12 12 12 12 12 12 12 
78 Kavitha 12 12 12 12 12 12 12 12 12 12 12 12 
79 Jayaraman 12 12 12 12 12 12 12 12 12 12 12 12 
80 Bhuvaneswari 12 12 12 12 12 12 12 12 12 12 12 12 
 
 
 
 
MEPERIDINE 
Sl. 
No. Name 
Spo2 
Baseline 5min 10 min 15 min 20 min 25 min 30min 35 min 40 min 45 min 50 min 55 min 60 min  65 min 70 min 75 min 80 min 85 min 90 min 95 min 100 min 110min 
1 Selvaraj 100 100 99 98 100 100 99 100 100 99 99 99 99 100 99 99 99 100 100 100 100 100 
2 Sekar 100 100 100 99 100 100 100 100 100 100 100 100 100 99 99 100 99 100 100 100 100 100 
3 Raja 100 100 99 100 100 - - 100 100 100 100 100 100 100 99 99 99 100 100 100 100 100 
4 Vasanthi 100 100 100 99 100 100 100 100 100 100 100 100 100 100 99 100 99 100 100 100 100 100 
5 kalidas 100 100 100 100 100 100 100 100 100 100 100 100 100 99 100 100 100 100 100 100 100 100 
6 Mohd.iqbal 100 100 - 99 100 100 100 100 100 100 100 100 100 99 99 100 100 100 100 100 100 100 
7 Dhanasekar 100 100 100 99 - 100 100 100 100 100 100 100 100 99 99 100 100 100 100 100 - 100 
8 Arivukarasu 100 100 100 99 100 100 100 100 100 100 100 100 100 99 99 99 100 100 100 100 100 100 
9 Prakash 100 100 100 100 - 100 100 100 100 100 100 100 100 96 98 99 100 98 100 100 100 99 
10 Muthu 100 100 100 99 100 100 100 100 100 100 100 100 100 100 99 98 100 100 100 - 100 100 
11 Esther 100 100 100 99 100 100 100 100 100 100 100 100 99 99 99 99 100 98 100 100 100 100 
12 Mariyammal 100 100 100 99 100 100 100 100 100 99 99 100 99 99 99 100 100 98 100 100 100 98 
13 Kosala 100 100 100 100 99 100 100 100 100 100 100 100 100 99 97 100 100 98 100 100 - 100 
14 Unnamalai 100 100 100 98 98 98 98 98 98 100 100 100 - 98 99 100 100 100 100 100 100 100 
15 Pattammal 100 100 100 98 99 100 100 100 100 100 100 100 100 99 99 100 100 99 100 100 100 100 
16 Kumar 100 100 100 99 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
17 Kanchana 100 100 100 99 99 100 100 100 100 99 99 100 100 100 100 100 97 99 100 100 100 100 
18 Rajeswari 100 100 100 100 99 100 100 100 100 100 100 100 100 99 - 100 100 99 100 100 100 100 
19 Velmurugan 99 100 100 98 99 100 100 100 100 100 100 100 100 99 100 99 99 99 100 100 100 99 
20 S anthi 100 100 100 98 99 100 100 100 100 99 99 100 100 99 100 99 98 100 100 - 100 100 
21 RanjIth 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 99 100 100 100 100 100 
22 Anbukarasi 100 100 100 100 100 100 100 100 100 100 - 100 100 100 100 100 100 100 100 - 100 100 
23 Karmegam 100 100 100 100 100 100 - - 100 100 100 100 100 - 100 100 99 100 100 100 100 100 
24 Suresh 100 100 100 100 100 100 100 100 100 99 99 100 100 100 100 99 100 100 100 100 100 100 
25 Balachander 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 98 - 98 99 100 100 100 
26 mariyaal 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
27 Banupriya 100 100 100 99 99 100 100 100 100 99 99 100 100 - 100 100 100 100 100 100 100 100 
28 Senthilkumar 99 100 100 100 99 100 100 - 100 100 100 100 - 100 100 100 100 100 100 100 100 100 
29 rathinam 100 100 100 99 100 100 100 100 100 100 100 100 100 - 100 100 - 100 100 100 100 99 
30 Anjalai 100 100 100 100 100 100 100 100 100 99 99 100 100 99 100 99 100 100 100 100 100 100 
31 Nagaraj 100 100 100 100 100 100 100 100 100 98 98 100 100 100 100 99 - 100 100 100 100 100 
32 Devi 100 100 100 100 100 100 100 100 100 98 98 100 - - 100 99 100 100 100 100 100 100 
33 Venkatesan 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 - 100 100 100 100 100 
34 Jeyavel 100 100 100 100 100 100 100 100 100 100 100 100 100 99 100 99 100 100 100 100 100 100 
35 Sathyabama 100 100 100 100 - 100 100 100 100 100 100 100 100 99 100 100 100 100 100 - 100 100 
36 Marie 100 100 100 100 100 100 100 . 100 96 96 100 100. 100 100 100 - 100 100 100 100 100 
37 Prabahakar 100 100 100 99 100 100 100 100 100 99 99 100 100 99 100 - 100 100 100 100 100 100 
38 Marimuthu 100 100 100 99 99 100 100 100 100 100 100 100 100 99 100 99 100 100 100 100 100 100 
39 KalaiSelvi 99 100 99 99 100 100 - 99 100 100 100 100 100 99 100 99 99 99 100 99 99 100 
40 murugesan 100 100 100 99 99 100 100 100 100 99 99 99 99 100 99 99 100 99 100 100 100 100 
 
                                                                                                         
 
 
 
 
DEXMEDETOMIDINE 
 SPO2 
Sl. 
No. Name Baseline 5 min 10 min 15 min 20min 25 min 30 min 35min 40 min 45 min 50 min 55min 60min 65min 70min 75min 80min 85min 90min 95min 100min 110min 
41 Sakthivel 100 100 99 100 100 100 99 100 100 100 100 100 100 100 100 99 99 100 100 100 100 100 
42 Thangavel 100 100 100 100 100 100 100 100 100 100 100 100 100 99 100 100 99 100 100 100 100 100 
43 Malar 100 100 99 100 100 100 100 100 100 100 100 100 100 100 100 99 99 100 100 100 100 100 
44 Rani 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 99 100 100 100 100 100 
45 Jesuraj 100 100 100 100 100 100 100 100 100 100 100 100 100 99 100 100 100 100 100 100 100 100 
46 Sivanantham 100 100 100 100 100 100 - - - 100 100 100 100 100 100 100 100 100 100 100 100 100 
47 Iyappan 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 - 100 
48 meghala 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 99 100 100 100 100 100 100 
49 Ramya 100 100 100 100 - 100 100 100 100 100 100 100 100 96 98 99 100 98 100 100 100 99 
50 Selvam 100 100 100 100 100 100 100 100 100 100 100 100 100 100 99 98 100 100 100 - 100 100 
51 ganesan 100 100 100 100 100 100 100 100 100 100 100 100 99 99 99 99 100 98 100 100 100 100 
52 Krishnaveni 100 100 100 100 100 100 100 100 100 99 99 100 99 99 99 100 100 98 100 100 100 98 
53 Pitchammal 100 100 100 100 99 100 100 100 100 100 100 100 100 99 97 100 100 98 100 100 - 100 
54 Manimaran 100 100 100 100 100 100 100 100 100 100 100 100 - 98 99 100 100 100 100 100 100 100 
55 Sathya 100 100 100 100 99 100 100 100 100 100 100 100 100 99 99 100 100 99 100 100 100 100 
56 Sundar 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
57 Mahamudha 100 100 100 100 99 100 100 100 100 99 99 100 100 100 100 100 98 99 100 100 100 100 
58 Manish 100 100 100 100 99 100 100 100 100 100 100 100 100 99 100 100 100 99 100 100 100 100 
59 Dinesh 100 100 100 100 99 100 100 100 100 100 100 100 100 99 100 99 99 99 100 100 100 99 
60 Kannadasan 100 100 100 100 99 100 100 100 100 99 99 100 100 99 100 99 98 100 100 - 100 100 
61 Sivaprakasam 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 99 100 100 100 100 100 
62 Vasantha 100 100 100 100 100 100 100 - - 100 - 100 100 100 100 100 100 100 100 - 100 100 
63 Sabarirajan 100 100 100 100 100 100 100 100 100 100 100 100 100 - 100 100 99 100 100 100 100 100 
64 Thillairani 100 100 100 100 100 100 100 100 100 99 99 100 100 100 100 99 100 100 100 100 100 100 
65 Parthiban 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 98 - 98 99 100 100 100 
66 Jayakodi 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
67 Murthy 100 100 100 100 99 100 100 100 100 99 99 100 100 - 100 100 100 100 100 100 100 100 
68 Dinesh 99 100 100 99 99 100 100 - 100 100 100 100 - 100 100 100 100 100 100 100 100 100 
69 Sathya 100 100 100 100 100 100 100 100 100 100 100 100 100 - 100 100 - 100 100 100 100 99 
70 Swaminathan 100 100 100 100 100 100 100 100 100 99 99 100 100 99 100 99 100 100 100 100 100 100 
71 Shantha 100 100 100 100 100 100 100 100 100 98 98 100 100 100 100 99 - 100 100 100 100 100 
72 Venkatesan 100 100 100 100 100 100 100 100 100 98 98 100 - - 100 99 100 100 100 100 100 100 
73 Sivagami 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 - 100 100 100 100 100 
74 Dhanam 100 100 100 100 100 100 100 100 100 100 100 100 100 99 100 99 100 100 100 100 100 100 
75 Devagi 100 100 100 100 - 100 100 100 100 100 100 100 100 99 100 100 100 100 100 - 100 100 
76 Shyama 100 100 100 . 100 100 100 .100 100 100 100 100 100. 100 100 100 100 100 100 100 100 100 
77 Gomathy 100 100 100 100 100 100 100 100 100 100 100 100 100 99 100 - 100 100 100 100 100 100 
78 Kavitha 100 100 100 100 99 100 100 100 100 100 100 100 100 99 100 99 100 100 100 100 100 100 
79 Jayaraman 99 100 99 99 100 100 - 99 100 100 100 100 100 99 100 100 99 99 100 99 99 100 
80 Bhuvaneswari 100 100 100 100 99 100 100 100 100 100 100 100 100 100 99 100 100 99 100 100 100 100 
 
 
 
 
 
 
 
 
